	   SnapGene      (gacggatcgggagatctcccgatcccctatggtgcactctcagtacaatctgctctgatgccgcatagttaagccagtatctgctccctgcttgtgtgttggaggtcgctgagtagtgcgcgagcaaaatttaagctacaacaaggcaaggcttgaccgacaattgcatgaagaatctgcttagggttaggcgttttgcgctgcttcgcgatgtacgggccagatatacgcgttgacattgattattgactagttattaatagtaatcaattacggggtcattagttcatagcccatatatggagttccgcgttacataacttacggtaaatggcccgcctggctgaccgcccaacgacccccgcccattgacgtcaataatgacgtatgttcccatagtaacgccaatagggactttccattgacgtcaatgggtggagtatttacggtaaactgcccacttggcagtacatcaagtgtatcatatgccaagtacgccccctattgacgtcaatgacggtaaatggcccgcctggcattatgcccagtacatgaccttatgggactttcctacttggcagtacatctacgtattagtcatcgctattaccatggtgatgcggttttggcagtacatcaatgggcgtggatagcggtttgactcacggggatttccaagtctccaccccattgacgtcaatgggagtttgttttggcaccaaaatcaacgggactttccaaaatgtcgtaacaactccgccccattgacgcaaatgggcggtaggcgtgtacggtgggaggtctatataagcagagctctctggctaactagagaacccactgcttactggcttatcgaaattaatacgactcactatagggagacccaagctggctaGCGCTACTTAAGAGTGCGGCCGCGAGATATCTCgaattcggatccgcccctctccctcccccccccctaacgttactggccgaagccgcttggaataaggccggtgtgcgtttgtctatatgttattttccaccatattgccgtcttttggcaatgtgagggcccggaaacctggccctgtcttcttgacgagcattcctaggggtctttcccctctcgccaaaggaatgcaaggtctgttgaatgtcgtgaaggaagcagttcctctggaagcttcttgaagacaaacaacgtctgtagcgaccctttgcaggcagcggaaccccccacctggcgacaggtgcctctgcggccaaaagccacgtgtataagatacacctgcaaaggcggcacaaccccagtgccacgttgtgagttggatagttgtggaaagagtcaaatggctctcctcaagcgtattcaacaaggggctgaaggatgcccagaaggtaccccattgtatgggatctgatctggggcctcggtgcacatgctttacatgtgtttagtcgaggttaaaaaaacgtctaggccccccgaaccacggggacgtggttttcctttgaaaaacacgatgataatatggccacaaccatggtgagcaagggcgaggagctgttcaccggggtggtgcccatcctggtcgagctggacggcgacgtaaacggccacaagttcagcgtgtccggcgagggcgagggcgatgccacctacggcaagctgaccctgaagttcatctgcaccaccggcaagctgcccgtgccctggcccaccctcgtgaccaccctgacctacggcgtgcagtgcttcagccgctaccccgaccacatgaagcagcacgacttcttcaagtccgccatgcccgaaggctacgtccaggagcgcaccatcttcttcaaggacgacggcaactacaagacccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgcatcgagctgaagggcatcgacttcaaggaggacggcaacatcctggggcacaagctggagtacaactacaacagccacaacgtctatatcatggccgacaagcagaagaacggcatcaaggtgaacttcaagatccgccacaacatcgaggacggcagcgtgcagctcgccgaccactaccagcagaacacccccatcggcgacggccccgtgctgctgcccgacaaccactacctgagcacccagtccgccctgagcaaagaccccaacgagaagcgcgatcacatggtcctgctggagttcgtgaccgccgccgggatcactctcggcatggacgagctgtacaagtaactcgagtctagagggcccgtttaaacccgctgatcagcctcgactgtgccttctagttgccagccatctgttgtttgcccctcccccgtgccttccttgaccctggaaggtgccactcccactgtcctttcctaataaaatgaggaaattgcatcgcattgtctgagtaggtgtcattctattctggggggtggggtggggcaggacagcaagggggaggattgggaagacaatagcaggcatgctggggatgcggtgggctctatggcttctgaggcggaaagaaccagctggggctctagggggtatccccacgcgccctgtagcggcgcattaagcgcggcgggtgtggtggttacgcgcagcgtgaccgctacacttgccagcgccctagcgcccgctcctttcgctttcttcccttcctttctcgccacgttcgccggctttccccgtcaagctctaaatcgggggctccctttagggttccgatttagtgctttacggcacctcgaccccaaaaaacttgattagggtgatggttcacgtagtgggccatcgccctgatagacggtttttcgccctttgacgttggagtccacgttctttaatagtggactcttgttccaaactggaacaacactcaaccctatctcggtctattcttttgatttataagggattttgccgatttcggcctattggttaaaaaatgagctgatttaacaaaaatttaacgcgaattaattctgtggaatgtgtgtcagttagggtgtggaaagtccccaggctccccagcaggcagaagtatgcaaagcatgcatctcaattagtcagcaaccaggtgtggaaagtccccaggctccccagcaggcagaagtatgcaaagcatgcatctcaattagtcagcaaccatagtcccgcccctaactccgcccatcccgcccctaactccgcccagttccgcccattctccgccccatggctgactaattttttttatttatgcagaggccgaggccgcctctgcctctgagctattccagaagtagtgaggaggcttttttggaggcctaggcttttgcaaaaagctcccgggagcttgtatatccattttcggatctgatcaagagacaggatgaggatcgtttcgcatgattgaacaagatggattgcacgcaggttctccggccgcttgggtggagaggctattcggctatgactgggcacaacagacaatcggctgctctgatgccgccgtgttccggctgtcagcgcaggggcgcccggttctttttgtcaagaccgacctgtccggtgccctgaatgaactgcaggacgaggcagcgcggctatcgtggctggccacgacgggcgttccttgcgcagctgtgctcgacgttgtcactgaagcgggaagggactggctgctattgggcgaagtgccggggcaggatctcctgtcatctcaccttgctcctgccgagaaagtatccatcatggctgatgcaatgcggcggctgcatacgcttgatccggctacctgcccattcgaccaccaagcgaaacatcgcatcgagcgagcacgtactcggatggaagccggtcttgtcgatcaggatgatctggacgaagagcatcaggggctcgcgccagccgaactgttcgccaggctcaaggcgcgcatgcccgacggcgaggatctcgtcgtgacccatggcgatgcctgcttgccgaatatcatggtggaaaatggccgcttttctggattcatcgactgtggccggctgggtgtggcggaccgctatcaggacatagcgttggctacccgtgatattgctgaagagcttggcggcgaatgggctgaccgcttcctcgtgctttacggtatcgccgctcccgattcgcagcgcatcgccttctatcgccttcttgacgagttcttctgagcgggactctggggttcgaaatgaccgaccaagcgacgcccaacctgccatcacgagatttcgattccaccgccgccttctatgaaaggttgggcttcggaatcgttttccgggacgccggctggatgatcctccagcgcggggatctcatgctggagttcttcgcccaccccaacttgtttattgcagcttataatggttacaaataaagcaatagcatcacaaatttcacaaataaagcatttttttcactgcattctagttgtggtttgtccaaactcatcaatgtatcttatcatgtctgtataccgtcgacctctagctagagcttggcgtaatcatggtcatagctgtttcctgtgtgaaattgttatccgctcacaattccacacaacatacgagccggaagcataaagtgtaaagcctggggtgcctaatgagtgagctaactcacattaattgcgttgcgctcactgcccgctttccagtcgggaaacctgtcgtgccagctgcattaatgaatcggccaacgcgcggggagaggcggtttgcgtattgggcgctcttccgcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagcggtatcagctcactcaaaggcggtaatacggttatccacagaatcaggggataacgcaggaaagaacatgtgagcaaaaggccagcaaaaggccaggaaccgtaaaaaggccgcgttgctggcgtttttccataggctccgcccccctgacgagcatcacaaaaatcgacgctcaagtcagaggtggcgaaacccgacaggactataaagataccaggcgtttccccctggaagctccctcgtgcgctctcctgttccgaccctgccgcttaccggatacctgtccgcctttctcccttcgggaagcgtggcgctttctcatagctcacgctgtaggtatctcagttcggtgtaggtcgttcgctccaagctgggctgtgtgcacgaaccccccgttcagcccgaccgctgcgccttatccggtaactatcgtcttgagtccaacccggtaagacacgacttatcgccactggcagcagccactggtaacaggattagcagagcgaggtatgtaggcggtgctacagagttcttgaagtggtggcctaactacggctacactagaagaacagtatttggtatctgcgctctgctgaagccagttaccttcggaaaaagagttggtagctcttgatccggcaaacaaaccaccgctggtagcggtttttttgtttgcaagcagcagattacgcgcagaaaaaaaggatctcaagaagatcctttgatcttttctacggggtctgacgctcagtggaacgaaaactcacgttaagggattttggtcatgagattatcaaaaaggatcttcacctagatccttttaaattaaaaatgaagttttaaatcaatctaaagtatatatgagtaaacttggtctgacagttaccaatgcttaatcagtgaggcacctatctcagcgatctgtctatttcgttcatccatagttgcctgactccccgtcgtgtagataactacgatacgggagggcttaccatctggccccagtgctgcaatgataccgcgagacccacgctcaccggctccagatttatcagcaataaaccagccagccggaagggccgagcgcagaagtggtcctgcaactttatccgcctccatccagtctattaattgttgccgggaagctagagtaagtagttcgccagttaatagtttgcgcaacgttgttgccattgctacaggcatcgtggtgtcacgctcgtcgtttggtatggcttcattcagctccggttcccaacgatcaaggcgagttacatgatcccccatgttgtgcaaaaaagcggttagctccttcggtcctccgatcgttgtcagaagtaagttggccgcagtgttatcactcatggttatggcagcactgcataattctcttactgtcatgccatccgtaagatgcttttctgtgactggtgagtactcaaccaagtcattctgagaatagtgtatgcggcgaccgagttgctcttgcccggcgtcaatacgggataataccgcgccacatagcagaactttaaaagtgctcatcattggaaaacgttcttcggggcgaaaactctcaaggatcttaccgctgttgagatccagttcgatgtaacccactcgtgcacccaactgatcttcagcatcttttactttcaccagcgtttctgggtgagcaaaaacaggaaggcaaaatgccgcaaaaaagggaataagggcgacacggaaatgttgaatactcatactcttcctttttcaatattattgaagcatttatcagggttattgtctcatgagcggatacatatttgaatgtatttagaaaaataaacaaataggggttccgcgcacatttccccgaaaagtgccacctgacgtc  :Q                    !         #            *       *   "               (                     !                                                 #                        "   (              -      #   )   %   %      .            $                            !   &   "      #         $      6                                                                             !                     "      
                                    )            "                        *      	                                       
                                    *   "         !   %                  "         #                                 )            !                     %   1            (   %                      %               )   #      #                     #                 !            4   #          %   %                )       8          šKT„Ê˜„	…	†	‹	�	Ÿ	 	Á	ï	ø	ù	�
ž
Ço2oñ|þ¯ëý  š1›½ÙoxË§¡	ª	Â	nNSgÔòO}ÿüÔ¤C®{ · °L‡	Œ	ú	#
«
Ý
ÊuÅp°UÃþ  Ø �!U…]cVw™×‘	Ì	ð	Ÿ
ð
�È$cp3À’D¨ìƒ 	 d -´¾p†¤”¢	çóyÿ~¥! Ý'bŽÀ-3	Z	«	á	A¹ÐO›ÇùP
/µý2À DÝd|Œ  ‡œ©#]y¨¥	Ã	o&8>Yuk®àó â»�Õð¯üÖ ›2ÚÌ3,‰¸–	/ T#ÎÚhÕ—#  ±eèÕŒýJbã7	t	ˆ	�	É	$
)
Þ
Ëvì˜Æ†,Õë‰eV E¿iû	&Ðåu�´Ê>_œ ¸ mŽªÒ,
¬
ä
‡eÐq¼*o†íe±æ%Äÿ g Mk*‹X»»2±Ü8ó* ½ ‚Î7X^dÄW2Þ	
 
É%d³Vf~Ë°ƒ“ÉâH‰¨ÒÁ�£í„  � Ï@sÊºs”3x�šÛ³’	¹	Á
è0‘q§MW�+h* • U6Q};VÍ	Õ	ñ	„
 
Ü$Ÿêü~†¡ºY¥¶É4OÁæÁÜÃVEù©Þ¡" Ù L“Ïä"/à†»ñC§È8Øñ
¼Âöm¢½q*<îµ e ¨
[aHT‡ÿÕX	£	Ü	ºÀåèô<|i�„ÈU¦ 
 ?q™z2z”›âÎ~ n .µ¿�2¥•Îo	Y „Þ9.LÄh” y -@ .oXj¼’Òñõ*ücªôÌgÄ	YÒ( © Ó|€�™Zf�ç	MtÔ|4	¬	ì4ÝIPg'ùú¶þæ"˜Ee¶ Y(.Ý[	â	Ñ–äœv¸ÐQŒ3‡ÅÞð�í ¬ £Þcs¬ºô�Èlø€}•â AÁÃe×æ%æ	BPøB0QÁÆ 8 Ñ h^ægÄ	á
9Vª©�áT Þ ˆ›õ$éý
ð¡ã–ŸÆ°× ð �¦	²
Ø
epy—LZ¯5�£¼|Öäå!    ªzïƒ©ê',?vÄläôH�›£ñýf»Íûý2    r~§ú´þ=Í4:-0Š5¹!=$cV‡Ödw¶! ž ê œÑZÌJ—	¯	4šÛ“”=‡ ÷ œ3“Ûdñ~ô0£ŒU·i­˜™†a š Yd)s¯{´½ß>q�-	;
É
ßãÙwÏ{žÒcÐ� ²…+Ð‰	Ž	Ê	'
*
î
-·Îw™»Ém‡éì¾‡ fzþ²Kcä›9
ß
ãuîÎS_fW ] _ ÜéížRu	%
¾ÀÌ³ÇÌ-I‘Š…  s �ëÖ� ÇÌ>ø"	8	¸
í7j[ÁKÖ¼ÚÑ& p ªq	
ë
à/Ï?`“R FŽÀë=Ç³æ5v�µ0N	P L �·ÞNïItü	ï7š'„”�Ñ Ë&�‡æ * Ô Óì#Dwj§Áûj a ç p (		@ã½j4B;=or×ÿ–	’ C ¹ ü 7Éû«-
ˆÆ+Öî)ÏA]Æç&Å À n�ÁÅï ÓÝ	CÍpÅ‡K«fnd˜O# 0…†K„P—}
­
å
"7ˆfµÑ(G[r¿Í(6ZàtU²ä  h èw¥+r›LX¼3Ž• uªýT·4w	Ž
ÂP¾ÚC~¼€ÝŒDv¦ ¦ ó5Nl¦¶½Ðk	Y�²9k2Ë TüaŒF	Õ]ètê†ô kŒ	‘¾ÞÇ	ß	

!
L±´Ìeïz„ÇÎãÓcä‹Ô w Ï —­Ï8Y_eX3�ªeâóg…ÊŠÆdÌÂŽî… ¾ å 5ƒíGPÅ	7
&á±2‹@I©¤M" u Å ‚C


2
L
T
ÂÊ
/9WY=í7x”µÃj‚h¹( ÐAt*ƒ·»ÉêÑ"“	¶	4
åé-1·bÄý1r:¨«Ávy„,Ã  { ‘ gþt•4Žl›	ó;T¬7$NrÁîjÜ[is  > ¥ BjyÜ´a	f	º	
øü@DHºì,[?=Tbýdi‚4:¹ ! Ë�Œí›ZÂ
^’÷MX/(- k Ç VzW0x™q¡@C‘¾ç¾	ì	” ¢»4Z¦·ÂöÝüÂa²ÄEAFg\¾ † Z7~„×?
Ô‡]ÊÓç¦!ØúH{# Y – ² Ê JRÙ’•ÎÖ	c
…
º
ëýqÀˆ¦þÂ!¬DžÛJª¢W) 3 R /<Î	ò	Z
“
¡
Ý%
¥9‹5P/Ý9–¦·×Wz¹Å:B¹×ß‘¬ë™Ó% ; ”ÐÖåÔEÉ¡¤�
v½Ãn­°l‘	?Œ£¾,¬Ùö=Øý@p% H Ú “ç\áèòDj µô			:	H
x
ò
;K“]r +¡®%ùYuI» QØ‡ïú$	€ÆÌ÷„DN¯îlï‚'. #M]kÇðö¯#0a¼!œ¢¨9FeÙ	
N
V
ø
bnwƒ�˜ÌïÑ_Š	@\_¶Ÿ ¶ ™n JS\bUvÖž	÷	ª
Ü
mÉÆR1ýÓ§z‚Âü a~\+…ˆ Y	•	¤	æ7=ÿtjÙ	.–ºŽïûc f jÔh©Iâ6	s	d»…1É$ � ” ¼ ã¹º¸	Ý	Ûç#/»Áéõû}NU‚á);U§ÑV€Àg ,>Œ1Ô¹1{)û©€ƒÃÝ8K « @eÓÖ${å	ë3Ü•÷†—Åì  Ý šôîUœ {šãü•äS r›=p®	 3™Þ“Ï r ÛŽË·
í
,âiè½R»„Ð ) K o �¶Òë"Cv¦Æp	î6ß™
%/MQi  B û /À…'JƒO–	Å‡Zi'ß(:@~T\cÅ• S¥3¤û`ÏÔO\K…1u! ‹�¬½FO~

6
K
S
Á	Káòà<d„ìÍ Åbc
ãLÓ& z )A‚éìÐ!Ykš	µ	ä÷,?Sö+6<Sü#hªÀuxí.Â9Z¸" … .y‘/w˜p ½ë	’
“Ó	3ý ¥«Á `Ö¸@AG«ê G "ÕçÓ´î	>õ
^­$øü# Ž “ â`i}R[g
*u„á5	�	lQTºà(:�Òî¿úfy� ª ‹šó0<Õío­	ä	0TÝ(úŸ’7–™R Úê¤I‚úNÅÓí5Þh˜~ç$PtÏ$ F „ (xÔ��æEv—èŸÏ}
‘
ö>Jàƒ5Rû	·ÿ?#tFâ· _å /nã	Òõ=—¹4Qß'9ž6Œí#áÎx6 } Ðãä®¯°±ÞßS	Ï
Ð
Ñ
‹Œ�Ÿ �&78pq45ˆ‰Š‹ÆëìÞßàÍßñ]^kuvwîï ~ H	ÑäZ7T	\	˜
Ž¡žw0DMÑrlŽðø Â)Ÿ²à?áÒ
<åxR�PTÇ2óàò_ô I{­ 
~ºådt8U	�»õ®Ÿ	x'�iGÃm�ã x–_ßìP	²	)�19Nèð`�©³~–­ñù  ¡ [¤]	¢­±K§EÒã.98 . ­ Ò™
�ÉµmùsN a�ÖÆ£³@ºØw§uÂl¸á ‹ í Oá�±ù&CFœQ–æí·Q`õ >Ãð:6«çÉÓ
=h}ùCy$xóÈ3™Çó. B*ÂÄ÷fMâç	MVŽS1ŽRŠUôp   +J®/c»9vïûÆ‰¶Ó	â
�W£|– 
(¹Ÿ#) § |'çåV	�:JŠöy¶âjà,ÄËÐ Ò ƒæùuœ¼‚ŽÍÕ�ä 9 åie_“h¼	Å	ñú9Bµ«ª¯]‚úHGU‰n @  ‹—‰l%³	þ
*ZÞ:¿S|a‚Àú <y&àñêQ	j%2Oÿœ—ñ6±ò ß ')ã$œ÷íÁ‘ñ(*®Ü á `ö¼–ðé¢ä Çª´—�Ø ¢ í ô o¤÷±û
q^	h	§	„M[`óÓ/�:xÚ³È ñ ÿ P]\
Ù
®L+f½}å6° € ¹žþ³
fqz˜£¨± žFV×oæ»Þè ¥DKz		]²‘×‚Õ°6¤dä§9y  WVl{ü/c	š
õ
@žéî´)AKÊnt|ž„ü  	×à{ÓÃÞ„ªë- .“Ö–?~‹¶ÓúkèOê¼×¿!  / N ® Hž{€ˆ!	SþF(w�mõ†"‘¤ò^g±þ3<  «%“ðþ	rœÅåÙñqIœþx#-ÎL  Ö C½˜×È5AqÂ1‹Ù6¿
"d$ë÷­¢¬Š bb>äï.xº%W™òeO—Ã�¹ s¨ûLµÇ¤ë´Î;»{
é
 >ùÍmâ" ã ‘îÿ
0
¨`¾ˆ×vx€·Õ� Ò²˜	5—õ”¸Û>~a" , ‰ Œ Ÿ î�¡	PõG:�©¯¸Í÷KÃ°	D�R”›.BKáënRö ë :Õ%Fy‘šã‘ú‡çÜî)É¾Ú	
 øâ['B
Gé•ýˆ ÄGNÌõC	>�úFVD¸_=ª¤±1Ab/ ø ;i7¬Q¤™yôÿš ?�Ë4<Ü‡òèD
Ô
š4ÈC # ”ñe­Ê=	1Ii~ýjz%®ÛÉ‡lô"™Ÿ › Z‘gž<
àÐ|©˜2ßdYÉÛ‘¶ `ÍÅøŽµàNè	WÚÝ€¤VD®õqI *+Êúm¾TÄ
ä†Í�ŸTæ,øZ e¬Ct°Ãl|¬¸Ú?])\rã.	Ê
Nxê�ÓS‹Ñ* ¯0€¼wƒ—ƒ	Š	�	©	À	Ë	î	ï
t�bÄn¿‘CT c ,³†Ü�",2£“·2	.@¸ÏòXx"š­ßþ´¿Ü  dÑü)aŠ(
+
ã
†—)nº³ê=^Û7ˆ›$d) KTÎ?rÉ5P|Î.Í:ð¦ÇÔ	žX¤}¡¼Êå¯Gˆ¦í´ * m ÿWiW	n	Û	‘Ñä;bƒá-Tg}XÑ ¨ r{˜YÜ€æLdsåOó÷Hø·Ïkå!”µá 7 ï g~èé×
à
ü
d–+K©¨ÃïãG¢ÅÌ1" ™ é ö Xq}¦ù(’³ý<z³¼œ,	:
¢‹vUz¬cµ<…`  \ ^ ê*�÷&
¶½¿Í6ºÈlËÍHJÙ^ Ó Ý©îsÀ
ƒ“.Î’†å ` „ÄúoŸ		6´FÄÕÌm<qÖ‘ çò4vSE	j	v	Á½ÙçB}s�Wéj‹CÊ t Ä j�ìÝÆ	.°16Š´ÆÂigŠ   ¤ f¶ýŽ‹È`	òû:C¶]ü«¹acLqÀÛ3' 2 Q X ± É I”Í?B�½	¹
¤8\Š‡õûD×I½zV˜Ò* : Ææ×` i›¡Eù		#	9	G
uË¬îk�Ð^ƒ‹’?\×�?tHžo µ » ˜mI¹r	ö	©
Û
ÈúT0Ðû	 =Óÿ
¨û”Jë A q ú ŒR&£ 	¶
ì
+N[áh}Sbƒ !Š€«´	
R
ß;¤À¿@aéÁ E ƒ 'Šáò
k‘ÑO
Q€ GÁ­>àR	—
Š3P 6�
"1òÌó z^ëO	(°¦&´-hçM8_7² =�ì9ÅÈ›¦g|#w¶ò˜  *‚ä.øuîÒ	ð8´‰µÌ+ž(ˆ à (#%köðÀi$•›') ó þ ¸öO\ý	J~	\ƒ°Ö�_òŽn5¯²ÇÝç M ßU�Âý	R›’Õ(J…ŠØÒð!p{�ç]é"¾ Õ â B¼íKapÁ/
¾
½#ñêö¬œ¡« + ˆ 9Ô$Ex÷™9¨®ÂA
-Úü}ÈÙ
 ;M†Ëü@kB˜ž _kÙSÌé—£Þå+C­Èµ b Í>qÈÛ!¨	…ñsaä ¾®�<Ú6šÛ ˜ è î õ p¥ø‘²ü;q—Û+	Ö
cNÂT‚äF¡
“´à [ Ãñ)r	i	5ØAkrÔl;pØ É £ Ã µ		_	F
t\-‰Šô05‰Cp€>fsy—� ´ º Q¢¨
µ
Ú
ÇM¾èê D ‚  ]‰¬ß
'‰š¥¯,gÐ	L7^Ë ò ý -Tüh¯³#‰×ïoœæè!'±½Æ 8A»^LÊ˜.
½
",Ý*~B¬Ç?A Â p�ÂÇð´Ú	bsð ×qˆko Ùe™ß � º—¡Þ§
´
¼
&g™¤®²!ç Ê@¼é* Á oÆÿÔar©ª«¬­íîïÿ!ÕÖ¨ÎWXYZLMghij§ØY?§¨" Ÿ6ŸÞ QÕJ	_
e
r
‡
{"D©ŸÏG[ÆFN¬ñ
¨pZEP© Ì ¦Q˜`
~
	|#EƒÖH7s ÄÀù)7/qVðè LL…Ð÷'�êæ
±H\[õu¤¨6Fª! 8”ô$ý{	€	Ø	f
s
#^³’gÒªGQ\_²eòá©:[zåQ% 1† 7 ßER‡Ö'	K	i
n
ˆ
®
8‰Ø¶)¥ÐÇåGš O­Î³£  §Š0±›
V}$„ŸÿÅMo¹Áú*0ñé W¡¦,Rm|ýÌòÇ
;×ïµt¡œu éx°™ApsËY½¿4}r�…“–ý$ i Í XZd	a
v

ö

Fê7I*8BL¤°8ŸW ' MÑìÃ	Q¿/×Ôû�%\»Paë©7À" 
v«Øþ|¸Ô5CMø(‚ßë�
KI.ÛRÝ|”é½n§ø« áU†Äx	¡”²ø|Œ·½Þv¥!EwÕØ›Î –g…«ç
D„—@I]ß';¨ÙlËöÙ�G# 0 5 O ¯ 3m‹§Û|�‰	l	�	Ù	´ÉÏ)§ «`l‘³:h²\{R I!ô·¾Ñþ|	Ð	ô	•
ZH³f¢ª l3 69O•õ"%g
$3_ÓR]‡˜€âD¥ó=›æÿ4=¡  % §1Ÿ´X>¯t
TÿG“hx‚nöÇó#’_;öÌ 2ó¬Uýñb¯
k€Š•j·éÆÑÚ›YÏërJ$®øM ¡¡©à9Ù�¦éuæHòP<‡yá*. 8Fˆ@×&”�(	G	L	\
o
*z�æÈ¡É�ÿíõ¤   T ‡¶ºS	?	ÿ	j
‰
£
Öß'^s1®»õ‰´Ï  × ™ØÉ¦"
œ
#MnfÓðN{û®£B­ê  ¨&¿à	% ÍÆøá1ÿ‹Õ D¾l�
ç‹È	WÏë%…ºÏäì+tŽÔd°åò) ’ß6BWr“Ã2ŒÚ17²

ƒ
À
~l… ¹²µÈeÀÛpÂÈøLÝŒ¢ x ˜?§	-Z`GSnþy»Í¿“ðôhXšóËfÇÍÃ“ X¢ÒÂ«fã&AŽu‹PÄï  Ð åf‚±
x€4¢ežºú! � cc®Ð9Þð/Y}Ë4IóÈ
â <Øb¶~†�v’Ñb˜�† „yìÏQŸ±Æ
=š!	8
²tíZÀ�†% €MêH<ê
ú²Œ4O ¿ æ 6ÈîÜ|
!B'?âÌ3¾AJª5YÎsn—þãN t©ü¶¥µ¼�
qš~�”¥# v Î ä 4–B€

1
©8Xîwy?�Ë¸ =  ie	
3
GaÃ0ëZ9>ƒir% j Æ YƒØÖæ>
Y
b
p¿¥Ò.Ü8C•�¥±¶yÄÚ9f[¸Ö�1 P\j’ïõ®[ÿDód £
M
U
w
€
÷
amv‚Œ—Å¯Ë:J+CM‰«®Ø[ík &Xº ¸Ó”	·	Úæ".6cÅþs0MØü-•¦¹bÁ Ü +dÒ#ê2¸Û˜ö‚ÂÜz…ãÄ ( J Ñ!Bu„Ê_Ä†J&	'¼?Qº0[( ¼NÒë³ í	™	ê	5
J
ã
+RÀ2=;ë_Õ"]©¬wbì÷ûª-8K% � ’ Ùé£whDQHu–ù);ƒžÎàìÄœ	�
/SÜßS‚}>s•¾sù  | Ïâ^žãÿ6mÎ
;žô</CLwÞ%oOSêÝ\jt÷ -   w•¬ÿ}¹±	Jœ­8€âFÂï¨¬ Š `Õï¢
Nö5�ª°¹øLvELU•�ìt‰k·o- ¦ &b’›úäÅˆµ»	ùAœI¢\{•ù�¸ßÊÔ"FÏ ? &;ŠâY»Ý¾ïþR{5¿œÛ ì n£°úCpg	y	
�ÔUc*ew¦xÙº
% ÖGVz$‡ kz’Ýû.	b	ô
ýEq€Ÿèí-³@•>}jw°,ƒKÖ; —êÇãî
z
è
_ø˜N–ÌÔŽ‰ �ôFâœ·ö†“AJàèê(ôm½ " ÊFhP¬<	B	C
HE^<©Ú£°þ0! «ÌÉùl��«·\([Ã
…Ü¨X÷YÚ)H) S4O{Í-ŒÌ‚(1¥`–¢’1	‚	¿	í	?ŽW!¬ÃmÞýF³B¥²]³cS# 6 l WX}y»rVhèm	Ú	û
•¡Ð*¨òG§÷a«b ´;„|0 3n¨¿ö	D	
µ¼æ5|E¹’ÃÊVËèGiB]# 1 P W ° È ÅHÜüŠšAD�Ê£û[�¸Ï†‘`>b³ÅÖh¿2 ù <H¸Òÿõ	Q
ùg£§ úI 8ÄN	–
f{¥"ñ!  õ["jõ¿}	Ñ	Q[‚Õ€ˆ^ÔI´šz\m4 ‡ :J…oÀØ8­R@
ËèÙõû«›| Z — Ì=Ú:–*	E
Õ
4r,ˆÁ‰ÿS­�ãE5œ ³ @,KSˆ"ˆÜn›K«> # ž5ÝP³–ÙI	^
d
q
†
¦
»
%`ìþÔ§ Eð	Ÿ¦XÉ>D¦  Ë 7“Ïóö#&€éü&	×	h
m
FP^±Ã™Ÿø.ô£ïç5¢  Y‰¯°Ëñu
Æ
U:þ6o£¯¸¾’#  & •fBJ HƒQ÷{Þ&:§ØÜ{$“ºÊ`Ø mÔ÷šÍ $ 4 02³WŠÚ=®Ï	ó	”
2ÈÎ¦k¡—ÆC<šõ !  S ¨òµ¹?	>	[
¢
Þ&j”iyŒ0èXºÈô;ˆà)­ì÷ æ%V’¥‚
k¸ÎêmÇ
¿ÒÚ÷às�KÜþA¯¡  œ ÑÁÝFÊH°
w¾á’@a�3}‘Ðaù’ ž<Û 	Œ
±ì™3XŒN4 < 3O[iô•­×ÕþAhòcŸ¢å=
X
`lu�‹–Äo®¤Ñ-ª­ÛBœ>ZÙìeZÊ%·q# I Û  c^	é	I
Ùâ!*…Ú<LêI^!,¥&¹âöú/ZJ _”è¢Îáv]âuÍ
:Þ�Œvs=ˆE¶r,  %m‰¢a¯ùoù#-
	ó
Xp�›žÓz”Qz¯+vÓJ% ÉªEÈéÆóEk�ª¶á¶õO;	A	
y
Û§çó¢¯WÓ¼ % V R,2Ëû'~¤º_•UgŽ0	

ú
åñ{ŽÎ…�ÉUa²ÊÕçƒ  ô9ÃGn¿M	P
P�ezøðù[ +²Øû%	)	H	]
l
p
¥
+‡EO°ï÷m-ž î¥ ²¸V‰ÙAˆ®ð	Å
ÇÍç ¢½(ö   Nh$À�Ü@;GÚä	W
‹
_tÍ`ë2A�W`Œ‹ ) $^lˆÈ®øDuÇbn"©,]t@	
Ì
Øá )o„ŽšÒy‹
¸ÒµÒ+   U ó±·Â1U±}£­¹^f	/		
O
k
¤
ù
Odyð`±¼Ôö8  fgñò­÷°»¼½¾¿ÀÁTÄÅÆm½¾¿Û*+:s			 
Š
Ë
×à(cx™]^_¯°TUVŠ·ÐÑ  .  qGACNNNNNNGTC,CCAGGCCTGG,GATCCGGATC,CCWGGTACCWGG,CCANNNNNTGG,CCAGGNNNTGG,CCANNNCCTGG,CCAGGNCCTGG,GCACNNNAACGTTNNNGTGC,CACNNNGTG,CCNNNNNNNGG,AACNAACRYGTGCGTGC,GCACGCACRYGTTNGTT,GCACNAACRYGTTNGTGC,AACGCACRYGTGCGTT,GACNNNNNGTC,GAANNNNNNNTTGG,CCAANNNNNNNTTC,CACNNNNGTG,AACACNNNNGTGC,GCACNNNNGTGTT,GCANNNNNNTGC,GAACNNNNNNTCC,GGANNNNNNGTTC,CAGNNNCTG,CCAGGNNCTG,CAGNNCCTGG,CCWGGGCCC,GGGCCCWGG,CCWGGGCCCWGG,AACNNNNNNGTGCACNNNNNNGTT,GACNNNGTC,GAANNNNTTC,CCWGGTACC,GGTACCWGG,CCWGGWCCWGG,ACNNNNGTAYC,GRTACNNNNGT,CCWGGYRCCWGG,GAAGNNNNNNTAC,GTANNNNNNCTTC,AACGGCNNNGTGC,GCACNNNGCCGTT,GCACGGCNNNGTT,AACNNNGCCGTGC,CGANNNNNNTGC,GCANNNNNNTCG,CGATCNNNNTGC,GCANNNNGATCG,TGANNNNNNTCA,TGATCNNNNTCA,TGANNNNGATCA,TGATCNNGATCA,AACCTGCNNGTGC,GCACNNGCAGGTT,GCACCTGCNNGTT,AACNNGCAGGTGC,GCCNNNNNGGC,AACNNNNNNGTGCMC,GKGCACNNNNNNGTT,CCWGGNCCWGG,AACTGGGNNGTGC,GCACNNCCCAGTT,GCACTGGGNNGTT,AACNNCCCAGTGC,GACNNNNGTC,GAGNNNNNCTC,CCWGGTCTC,GAGACCWGG,GATNNNNATC,GATCNNNATC,GATNNNGATC,GATCNNGATC,CCWGGCGCCWGG,ACNNNNNCTCC,GGAGNNNNNGT,AACNNNNNNGTGCAG,CTGCACNNNNNNGTT,GATCATGATC,CCWGGNNCCWGG,AACTGGNNNGTGC,GCACNNNCCAGTT,GCACTGGNNNGTT,AACNNNCCAGTGC,AACNAACCGGTGCGTGC,GCACGCACCGGTTNGTT,GCACNAACCGGTTNGTGC,AACGCACCGGTGCGTT,GCANNNNNTGC,GCACNNNNNNGTTCGAACNNNNNNGTGC,CCTNNNNNAGG,GCNNNNNNNGC,CCANNNNNNTGG,CCAGGNNCCTGG,CCTGGCCAGG,CAANNNNNGTGG,CCACNNNNNTTG,TTTAAACNNNNNNGTGC,GCACNNNNNNGTTTAAA,GCACNNNNNNGTTTAAACNNNNNNGTGC,CCAGGNCCY,RGGNCCTGG,CCWGGGNCCTGG,CCAGGNCCCWGG,AAGNNNNNCTT,GAYNNNNNVTC,GABNNNNNRTC,GAYNNNNNRTC,GATCNNNNVTC,GABNNNNGATC,GAYNNNNGATC,GATCNNNNRTC,GATCNNNGATC,GTYAACNNNNNNGTGC,GCACNNNNNNGTTRAC,GCACNNNNNNGTTAACNNNNNNGTGC,GATCNGATC,TAACTATAACGGTCCTAAGGTAGCGA,TCGCTACCTTAGGACCGTTATAGTTA,CTCTCTTAAGGTAGC,GCTACCTTAAGAGAG,TAGGGATAACAGGGTAAT,ATTACCCTGTTATCCCTA,GTTAACNNNNNNGTGC,GCACNNNNNNGTTAAC,AACNAACGCGTGCGTGC,GCACGCACGCGTTNGTT,GCACNAACGCGTTNGTGC,AACGCACGCGTGCGTT,TCCAACNNNNNNGTGC,GCACNNNNNNGTTGGA,CAYNNNNRTG,AACAYNNNNGTGC,GCACNNNNRTGTT,GTTTAAACNNNNNNGTGC,GCACNNNNNNGTTTAAAC,CCWGGCGCC,GGCGCCWGG,CCWGGNNCC,GGNNCCWGG,GATCGCGATC,AACNAACATGTGCGTGC,GCACGCACATGTTNGTT,GCACNAACATGTTNGTGC,AACGCACATGTGCGTT,TGGCAAACAGCTATTATGGGTATTATGGGT,ACCCATAATACCCATAATAGCTGTTTGCCA,ATCTATGTCGGGTGCGGAGAAAGAGGTAATGAAATGG,CCATTTCATTACCTCTTTCTCCGCACCCGACATAGAT,AACNNGCACGTGCNNGTT,GAACNNNNNCTC,GAGNNNNNGTTC,CCAGGWCCY,RGGWCCTGG,CCWGGGWCCTGG,CCAGGWCCCWGG,CCAGGWCCTGG,TTATAACNNNNNNGTGC,GCACNNNNNNGTTATAA,GCACNNNNNNGTTATAACNNNNNNGTGC,GAACNNNNNNTAC,GTANNNNNNGTTC,GGCCNNNNNGGCC,AACNNACTAGTGC,GCACTAGTNNGTT,AACTAGTNNGTGC,GCACNNACTAGTT,AACNAACTAGTGCGTGC,GCACGCACTAGTTNGTT,GCACNAACTAGTTNGTGC,AACGCACTAGTGCGTT,AACNNNAACGTGCNNGTGC,GCACNNGCACGTTNNNGTT,GCACCCANNNGTT,AACNNNTGGGTGC,TTAACNNNNNNGTGC,GCACNNNNNNGTTAA,CACNNNNNNTCC,GGANNNNNNGTG,CACNNNNGATCC,GGATCNNNNGTG,GATCTAGATC,CCANNNNNNNNNTGG,CCAGGCCT,AGGCCTGG,CCTCGAGG,GATCCGGA,TCCGGATC,GGCGCGCC,GCGATCGC,CCWGGWCC,GGWCCWGG,GATCGATC,GATCATGA,TCATGATC,GCGGCCGC,CCTGGCCR,YGGCCAGG,CCWGGNCC,GGNCCWGG,GGCCGGCC,RTGCGCAY,GATCNNGA,TCNNGATC,CGCGCGCG,CCTGGCCA,TGGCCAGG,CGCCGGCG,GTTTAAAC,GATCGCGA,TCGCGATC,TTAATTAA,VCTCGAGB,CCTGCAGG,CRCCGGYG,CGTCGACG,ATTTAAAT,GCCCGGGC,GATCTAGA,TCTAGATC,CACCTGC,GCAGGTG,CCTNAGG,GATCGAT,ATCGATC,CCTCAGC,GCTGAGG,GCTNAGC,CCTNAGC,GCTNAGG,GCTCTTC,GAAGAGC,GGTNACC,CGGWCCG,ACCWGGT,RGGNCCY,CCTGGAG,CTCCAGG,GGTGATC,GATCACC,GATCNGA,TCNGATC,GGGWCCC,GAAGATC,GATCTTC,CCCWGGG,TCCNGGA,TCCWGGA,RGGWCCY,TTATAA,AGGCCT,GACGTC,GTMKAC,TCCGGA,TGCGCA,ACCTGC,GCAGGT,GGTACC,AGTACT,GGYRCC,CCGCTC,GAGCGG,AACGTT,YGGCCR,RAATTY,CTGAAG,CTTCAG,CACGTG,GRCGYC,AGCGCT,CTTAAG,ACRYGT,ACCGGT,ACTAGT,CACGTC,GACGTG,GWGCWC,GTGCAC,CYCGRG,GGGCCC,ATTAAT,CCTAGG,TTCGAA,GCTAGC,GKGCMC,TGGCCA,GGATCC,GRGCYC,ATCGAT,CACGAG,CTCGTG,GGCGCC,GAAGAC,GTCTTC,GCATGC,GTATCC,GGATAC,TGATCA,ACTGGG,CCCAGT,CTRYAG,RGCGCY,AGATCT,GGNNCC,CTGGAG,CTCCAG,CTTGAG,CTCAAG,CGATCG,GGTCTC,GAGACC,YACGTR,CCNNGG,GAATGC,GCATTC,WCCGGW,GCAATG,CATTGC,RCCGGY,GCGCGC,GAGGAG,CTCCTC,CGGCCG,CCCAGC,GCTGGG,GTGCAG,CTGCAC,CGRYCG,CGTACG,CGTCTC,GAGACG,CCATGG,TCGCGA,GDGCHC,TGTACA,TCATGA,ACATGT,GTATAC,CCWWGG,CTCTTC,GAAGAG,GCNNGC,CCRYGG,GTTAAC,RCATGY,TACGTA,RGATCY,GCGATG,CATCGC,GCAGTG,CACTGC,CCCGGG,CCGCGG,TTTAAA,GGCGGA,TCCGCC,GAGCTC,GATATC,CTGRAG,CTYCAG,CAGCAG,CTGCTG,GAATTC,ATGCAT,CATATG,GTYRAC,AAGCTT,GTNNAC,TCNNGA,CAATTG,ACGCGT,TCCRAC,GTYGGA,GCCGGC,CMGCKG,GCCGAG,CTCGGC,CTCGAG,CTGCAG,CAGCTG,GTCGAC,CTYRAG,AATATT,GATCGA,TCGATC,GACCGA,CACCCA,TCGGTC,TGGGTG,WGTACW,TARCCA,TGGYTA,TCTAGA,GGATC,GATCC,CCWGG,GTCTC,GAGAC,GCWGC,GGNCC,CCSGG,GGTGA,TCACC,GGWCC,GCAGC,GCTGC,CCATC,GATGG,ACGGC,GCCGT,GCNGC,CCNGG,GCATC,GATGC,ACTGG,CCAGT,GGATG,CATCC,CTCAG,CTGAG,GGGAC,GTCCC,ACNGT,CTNAG,CAGTG,CACTG,GACGC,GCGTC,CCCGC,GCGGG,GANTC,CGWCG,TCNGA,CCTTC,GAAGG,GTNAC,GAAGA,TCTTC,GAGTC,GACTC,GTSAC,GAWTC,GCSGC,CASTG,ATGAA,TTCAT,ACGGA,TCCGT,CGCG,CCGC,GCGG,GTAC,AGCT,GCGC,CTAG,GATC,GGCC,CCGG,CATG,RGCY,YATR,ACGT,TGCA,AATT,CCTC,GAGG,TTAA,ASST,TCGA                                                                                                                                                                                                                                                                                                                                                           ,                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                           	                          	                                                                                                                                                                                                        '                                                     	                                                                                                               
                                                3         	                                    	         	               	   	                                             4         "   "      !   "            U                     _                                                                                                                                                                      ,                                                                      
                                                                                                                                                                                                                              
         	          	                                                                      '                   	                                       
                3   	            	   	     	 	               4   " "  ! "    U       _   r+  s;  sU  s‰  wí  |q  ‚³ßwoè
$±ÅoÁžAŸ	
O–±Ñês!3Ùð†«\é1J ¬=€¬Þ`�cMÇØýÀc99~ó;¾ MÇçkƒÐÏØþPŒ™ÅÎ¾	Ö	

?
Z
x
ó;n½Ã»&±·,PŠ7‹Î@yýó}áv†Ðo	v”†v†vvz'bô«\Ý{ƒ"‰Ù!,Á
H‘,¤ , ëDÝÊ#ùUg² –'ùÍ „ºÖz'§|$)ø˜ñ2Ñh#õr§ú´!”›$.gúÍ�biiÊÕi7	Á
ÉìWX
-ÛcÌÒÆlá’ÎßðBÇl¡¼p~ £¡DXrG÷ Ï5êr§ú´É‡Ö£!�ˆã ëšø Í -�X7õKÑ& �K&Ë!×ÿ \®+f6Gøs~ !� ™×�íK&ð©-!×Ì	ð	Ÿ
3˜¯¾#É™¬	5º	ø@[ü	šâÖé+�]„¸j¨
ûÙ|�K
S
É“ Ê©!ÀÕi„»8×7	 
¬
Á
Ü$Éì/VWµÞ±ÿ¢’ýèà�BQ{“÷úqÎKêè
øaGˆÆù£F^•/	Ø ›¾ømz±cBbéßr®¬Áwå‘�
	¾ÙÛW
å?’lá)¾	ì	ÂAÇŠ’lºbú�aù›zÍ  -!� ™X×Ì	ð	Ÿ
�í7õ3KÑ&ÀÞÎš”aGù›øz— 'ùw Mz~·t•Å		¶	º	H
V
�
åø-@^ó5;W[„ˆ¾Ù@]Ê ErùaÆù›z‘šº	ø@[K ©yî&ukó�šðüüÏ eVb	ô
è@ÉF^<0ÞÊÞ	Ëó¬ýñbk€Š•Yë$-›Xr¢’G÷ý Ïèà5 ã+©wA�£úBâç ›$� ç À�=cäå
-”›K0&$  Í Ÿ9x‹•°ë™ÑÙ.Û s«×1R—Mú€âD”ÞáÎ  ã Ï‡a  �
¾Ù¼åê	2_eZE½‘°Ëûê	2_›$ˆBËQ{�“÷­š ß{�[)V¹ñ¯tÄT) Ò"Cv¦Ài5|+
†å)$Ñ ©y¨&>ukó�ðü ªïÄäH›ýÍR,Ë'¤_•0	Ù!L,¥²¦Ëq2ÎÇ »™ê@C4
¢1Z·:a²Äg¨«v¾,Ø L!"/…»§8‹×Øð
Îµó$¥ÍmÒŒA eýJbãÞ
eV„öÙG‹Îó»ê4
1:¨«v,Ç ™@C¢Z·a²Äg¾#-
	ó
pž”¯+Já
V5AqÂ1‹Ù6¿
d÷°; Ç ‘”Ö»Þ™Ôê@C¡

4
Ãn¢­1Z±´·£,:¬a²ÄÇ=Øg¨«v¾,‹pR$,Ë'¤_•¥0	Ù!ÍmLÒ,¥²ŒA jyÜa	üDì,?=i‚:8 h^gÄ	ª©�TNÌ>�V¤±bI  ^…I&¹/Z]Ã	8à$’qw,K& $º`l Vhm	Ú	Ða|š1ÙËSgÔÕ]C½õC	D¸$˜ë2>A& l ³ Vhm	Ú	Ða$º`|Ê¼QºFB	E^<©£°0þ‡Öw¶¤Nh@äW
_tA!
Leïz¬ “d2Î0¯5i£Èl­ø„†9/4 <bq†šv�”#&5 §|l	Ù	¯
Ï$)§ÿ`Å�Ï0³:ø{û%	l
EO°÷-î|Zf	t4	Pe7ŽëÉ²›Ç-
9
Cu+vµ)AŒÆ_© ™Ô¬	'ù˜6õ"%g
]˜óæ4¡2Î„“d0i­†²›9
CuŒ_¬ ¯5£Èlø; ‘”ÖÞÔ¡

Ãn­±´£,¬Ç=Ø‹pFÊB	E^<©£°¼Qº0§ åö¶j…±u¤ ŠMv Î ä 4–B€

1
©8Xîwy?�Ë¸< 3O[iô•­×ÕþAhòcŸ¢å=
X
`lu�‹–Äo®¤Ñ-ª­ÛBœ>ZÙìeZÊ%·qkŒ	‘¾ÞÇ	ß	

!
L±´Ìeïz„ÇÎãÓcä‹Ô* Ô Óì#Dwj§Áûj… .y‘/w˜p ½ë	’
“Ó	3ý ¥«Á `Ö¸@AG«êu Å ‚C


2
L
T
ÂÊ
/9WY=í7x”µÃj‚h¹ù <H¸Òÿõ	Q
ùg£§ úI   ªzïƒ©ê',?vÄläôH�›£ñýf»Íûý2Ù L“Ïä"/à†»ñC§È8Øñ
¼Âöm¢½q*<îµæ%V’¥‚
k¸ÎêmÇ
¿ÒÚ÷às�KÜþA¯¡¦ &b’›úäÅˆµ»	ùAœI¢\{•ù�¸ßÊÔ"FÏG … • Ù "LU.6Qy}“ÏÕä"/‘àç;V†»ñ/Cw˜§Óp ´È8½Øî	Í	Õ	ë	ñ	„
’
 
ñ
“Ü$Ÿ¼ÂÓêöü	m~†¡º3Y¥¶É4>O¢½ÁæýÁÜ ¥«Áõ
 `qÃÖ*<V¸@E^­îù$A©µÞøüG¡«ê ? ¦ à &(*;‚Šâä&.b#%köøðu’›îúäÀÅˆµ»	Ò	iðù8AYœ´I‰¢»\{•Ýµù$�•¸¾ïþR›Ìß')+{žÊÔ"(5Fˆ¿œÏÛs¨ûLµÇ¤ë´Î;»{
é
 >ùÍmâ"  ¤ f¶ýŽ‹È`	òû:C¶]ü«¹acLqÀÛ3' ¡ [¤]	¢­±K§EÒã.98²¸V‰ÙAˆ®ð	Å
ÇÍç ¢½(öe ¨
[aHT‡ÿÕX	£	Ü	ºÀåèô<|i�„ÈU¦D ‚  ]‰¬ß
'‰š¥¯,gÐ	L7^Ëf … s¨û*Lµ.yÇ+j‘¤ÊÔëúh©´Î/;mw˜¾Ip »âT½6	s	ë	{
’
Ä
é
 “Ó	dä3>†Íùý�» Ÿ¥«Á T`Ö…¸æ1@É,AÍøZGm«êâ"W¡¦,Rm|ýÌòÇ
;×ïµt¡œu%  ,F     ¬  (        (¿þ`�îÒu¸îód¥=&ã¿ŽˆŠ,á$ŒÄÕjS�uC¡ñÖ�…ã¤
C*Œã¬Æ'Ñ™Ì¡Úhy)¥’[Zpi+dý™�+Ì§eéÂVÏƒ‡Ï×üý¡ËYaÉŠý’\õ�¯hrÖšœ%xýè4�µ"m˜õ'?ù¡ËXp•ƒóàÚcô�‡é€z¾z'nri-³š}‚Â¨4�µ€È0¨{p¯RïÚµ€JŠ ßUµÀz½V,—^óý¡ÍX$2'.fSDîàåäEýã§ƒ¦ÅigÞdSƒ“9éDŒ<Í»°o?îþÿÿùržó YCÂ#*.f)ª÷Ù£Ëªb?~âë¡ÄÚù º¿îÏT5Š,…4¯¸ë¡GW\¸“ê44Áýø1Ð�¸ÃÕOr&Q�øÕ7_ô�rˆJJ TKVïµ2k]@8PcôPŸö‰€n€>Â7c©ØŠ’Ä)U\¹ÿÜÈ*¾¡UÜa–`÷_`„ÔA8­ð#öø,NrWu+L‹Ã1÷çNáJÛ�÷ÃS�Èþßì‡ßáùÃ#HëO9ÿvÓqë­KÏcñCœ½Íöë­AÇyÔ3Ä!JÄwø!|Û…lzÔp×o€7S�'^uÓÝræmƒÇSEµ^µÏuÛpÓ#NÏyôÑwÿl1ÃüŽ8üu÷Ÿ„ßÒóøMQÿ\E3vã�+!óÏ·»�Äâu%ìK‘ò¥8m>Çˆúä£ÓÛŠ*?ïü�¯¡þ÷¿x¾¯–U„£lÚ.B-®k€ €45 hdÐØà0€î`ë„0T_N î@	¿ÜÏâL3iLÃ ‚œÍ29Þ�LþLüï«:ºþ¾®Ïr³Ã«üµ;•°¿©¼jHêpß±ÿU^†�!‚·$€öÏá‘ÂªÏê KÜ®¥’º+Õà]wµþnÂæº¡©”¨ñ«š
UXN—Uj\Å¥® Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û�¸NkÑI!:ª>Cª5TïÀN‰›Ú¬†ÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãAÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô36?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬VSý~=·«÷Ï>¹…B€ë²«ÀsÃ�†ûÓ0íŽ®³÷ýz*hÓ¦X)Õ•5“mÕ«ueMª«xÚä¢
‹Õíµ‰ºm‹‰Ÿ,~ääNƒ%¶dâ¯ˆ…h¦ó·Z÷uÙÄðSeH•> �–—·ihÊ3·�Î¯K_‹#Ó�¥…°õÌÀ*2hî¼ëìíáìã;+0ÄÂm;{T0–p¦÷E´—4bUMT=òUCÌ£ƒ*¯d;Ïÿ‡mÕ[íKD Å™QŸC*ÿàS¿²3»â¼�:|ø¼ú»úÀS Î®Ù;s‰	»JÂ$,¬ïS€â#qü­?8Ï¦ð—›.„½	Gqé³Þ4÷‚]“DÄ&$0ŽtJèR>^pçy]& ›Œî8SÒŸ¬Q($î†ðÕÕ÷Î	0ª¨¨ÔÓFœÍUíEêªç ¸s´�qW·)@j‚ØF›UAºß‘¾©ZUaJ¥mnT™˜I^‚áÒŸXém!ù»Ln.jÊÛÙ(ø{ü²$eçÀ@éöàÿHãXgÌG÷;|;Ñ©´ÖWÓÓÁ@ñ3E ¾5êo>öô¹¥¢�ND”’³Ò–JŒ×(£Ú9ÐÛ ‹s²Ê‚`ëkNð¯×PÄ§a¿ö(�UL);ëï(´RRƒÍ"›{`¦7�–»§‹cÛÉF:®!à„ž×Ô¶¸E’&0ÇÄ£º?µœYó=Ù4^¥R;m UÊë Å^íAº|â„oJÆ%ýì�ýxn´Ûªz·Ó*à!5WACU�5UeÁX¡g¶{¯ªµšhSjmš.ØLÙ¨Xš‘U•Õ�
ó7jÿH÷áË      �  ¤  '  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  !¯<?xml version="1.0"?><Features recycledIDs="1,21,0" nextValidID="22"><Feature recentID="7" name="MCS" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="901-932" color="#ccffcc" type="standard"/></Feature><Feature recentID="20" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6491" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="5700-6491" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6492-6560" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="19" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3404-4198" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="18" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1533-1535" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1536-1538" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1539-2252" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="17" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="946-1520" color="#a6acb3" type="standard"/><Segment name="ATG" range="1521-1523" color="#a6acb3" type="standard"/><Segment range="1524-1532" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4944-5529" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2566-2994" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="235-614" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3008-3337" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2296-2520" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="615-818" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3188-3323" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4372-4493" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6561-6665" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4590-4596" color="#ffffff" type="standard"/><Segment range="4597-4614" color="#ffffff" type="standard"/><Segment name="-35" range="4615-4620" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4635-4656" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="T7 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="863-881" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for bacteriophage T7 RNA polymerase&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4542-4558" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4566-4582" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  f<Notes>
<UUID>059de63e-f495-4768-a94f-65d6c943e1cf</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="1:38:26">2023.6.15</Created>
<LastModified UTC="1:44:25">2023.6.15</LastModified>
<CreatedBy>Triple Threat</CreatedBy>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
   «<StrandColors><TopStrand><ColorRange range="900..931" colors="black"/></TopStrand><BottomStrand><ColorRange range="900..931" colors="black"/></BottomStrand></StrandColors>  ,G     ­  *        *¿þ`�îÒu¸îód¥=&ã¿ŽˆŠ,á$ŒÄÕjS�uC¡ñÖ�…ã¤
C*Œã¬Æ'Ñ™Ì¡Úhy)¥’[Zpi+dý™�+Ì§eéÂVÏƒ‡Ï×üý¡ËYaÉŠý’\õ�¯hrÖšœ%xýè4�µ"m˜õ'?ù¡ËXp•ƒóàÚcô�‡é€z¾z'nri-³š}‚Â¨4�µ€È0¨{p¯RïÚµ€JŠ ßUµÀz½V,—^óý¡ÍX$2'.fSDîàåäEýã§ƒ¦ÅigÞdSƒ“9éOHÃÌÑ›±kóþïïÿÿ—)àñO:”<"2¢æbš¯}š<º Ö!ðWàþ.ºM¯�«þìõAcP¸¡bÈPSJû�NºuuË‰1þ£CLÿßƒûŒ=T÷"eß�PÃuÿH÷(„ d¢Dµ`îûS&µÔ…?E	ÿh˜á¸ì#v:�ˆ©,B•UË�ÿñ}À‚«ê]ÆfuöM@ÄŠß ‚?o‚ÄàpÇ%p÷R´È¼11�~pÔáþ­¸ß|58ü�àýþÈ}þœ24Ž´óŸñ÷aM7ºÔ¼ö?9ËÐLßnºÔp×�Gó<B¬@Ç‚Í±8P6Ç­Avøu8uç]=×.fØ<u4QpÛP…ëQ¼÷]±24ìñ÷ŸMöÃ?Èã�Ç_yøMý/?„ÕõÄS1·`¾8²<ð{°ØN'R^Ä¹?*Wó†Óìx�®J==¸¢£þÿÈúúàP�{÷‹êùeXAZ6Í¢á$"Úæ¸  AÓP€QÖMŽ cæ¸CEôàä ›ýÌþ$Ã6”Ì0")ÌÓ!ó�èôÏäÏÎú³«¯ëêì÷+<:¿ËS¹[ ;ú�+Æ¤Ž§ûõUèi+rHlþ*¬þ¡Ê½ÊêY {¢½^×{_æì.kª™@j�°ù ¥U„á©uV¥ÌZZâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ¸û„æ½’Cª Cä:£UNüè™½ªÁ¸mDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^4CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíC3cñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?×¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¦Ø¸™òÇîNDè2[`¶N*øˆVŠo;u¯w]œO6T‰Sàùa!9{v–Œ£;xüêô°ø²=8ÚX[\ÌÂ£&€ÎëÎ¾ÎÞÎ3°²°ãL&Ó·µC	g
ot[@sAQv!5PôÕCÐ_%T<Ê82ªöC¼ÿøq6ÝU±ÎÔ´BWñÐy•ô2¯þ;û#;¾+Çøó§ÁŸ‹Ï«¿¬2êí“·8�›´¬"BÊÎõ8"7ÿÊÓñóŒúo	y²èK×ð”w›=àÓOx%Ði4LBbCçD®… ƒåçw‘EÒj	¸Îã…=)úÁU‚Nèo]_|à“
ªŠ�M4iÌÑUPnÔQ¾¡º®p‡;H{r”¨-„iµT­ùê•¥VªVÖåI™„•è.)õŽ–Òß›´Æâæ¬­½’�‡¿Ë"F^qœŸnôŽ5†|Äs·Ã½›Me}=<4Rã^¦óïoKšZ(ðäII+=)d¨ÍrŠ=£�²·;,¨&¶´ï
ýqµJvÿbˆÕTÂ“¾°¾ñ²‹E%(<Ò)·¶
`ÓxÙkºx¶=¼”cªâIí}Kk„Y"c|J;£ðËYÀeŸ3Ý“EêU#¶Ú\®°UîÔ§Î(Fô¬b_ÞÈß×†ëMº§«}2®Ut5XóUPP1ÜŠ{gºú«Y¦…6¦Ð)¢í„Á�š…‰©Y]Y ¯3v¯ñT�~      �  ¦  )  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  !¯<?xml version="1.0"?><Features recycledIDs="1,21,0" nextValidID="22"><Feature recentID="7" name="MCS" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="901-934" color="#ccffcc" type="standard"/></Feature><Feature recentID="20" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6493" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="5702-6493" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6494-6562" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="19" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3406-4200" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="18" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1535-1537" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1538-1540" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1541-2254" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="17" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="948-1522" color="#a6acb3" type="standard"/><Segment name="ATG" range="1523-1525" color="#a6acb3" type="standard"/><Segment range="1526-1534" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4946-5531" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2568-2996" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="235-614" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3010-3339" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2298-2522" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="615-818" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3190-3325" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4374-4495" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6563-6667" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4592-4598" color="#ffffff" type="standard"/><Segment range="4599-4616" color="#ffffff" type="standard"/><Segment name="-35" range="4617-4622" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4637-4658" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="T7 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="863-881" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for bacteriophage T7 RNA polymerase&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4544-4560" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4568-4584" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  f<Notes>
<UUID>059de63e-f495-4768-a94f-65d6c943e1cf</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="1:38:26">2023.6.15</Created>
<LastModified UTC="1:44:21">2023.6.15</LastModified>
<CreatedBy>Triple Threat</CreatedBy>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
   «<StrandColors><TopStrand><ColorRange range="900..933" colors="black"/></TopStrand><BottomStrand><ColorRange range="900..933" colors="black"/></BottomStrand></StrandColors>  ,G   
  ­  +        +¿þ`�îÒu¸îód¥=&ã¿ŽˆŠ,á$ŒÄÕjS�uC¡ñÖ�…ã¤
C*Œã¬Æ'Ñ™Ì¡Úhy)¥’[Zpi+dý™�+Ì§eéÂVÏƒ‡Ï×üý¡ËYaÉŠý’\õ�¯hrÖšœ%xýè4�µ"m˜õ'?ù¡ËXp•ƒóàÚcô�‡é€z¾z'nri-³š}‚Â¨4�µ€È0¨{p¯RïÚµ€JŠ ßUµÀz½V,—^óý¡ÍX$2'.fSDîàåäEýã§ƒ¦ÅigÞdSƒ“9éOH0ó4fìZÁ¼ÿ»ûÿÿåÊx<SÎ�eŒ¨¹˜¦«ßf�.¨5ˆ@üø?‹®‡käêÿ»=PXÔ.(X²Ò¾àS®…]râL¨ÐÓÿ÷àÇB>ãU=È™FwãT0ÝÒ=Ê!((�Q-X;¾ÔÉ­u áA�ÑBÚ&¸n ûÝŽ§b*K¥Urä?ü_p ªú…Wq†YƒÝ}‚P1â·À �Ûà±81É\=Ô­2/@Äcßœ58…+n7ßN?#ø?²‡ç�#­<çü}ØSMÇ®µ/=�Årô7Û®µ5çQüÏ…+1ßà…ólN±ëPAÃ]¾ ÝN�y×OuË™¶M\6Ô!zÔo=×lAÃL�;<}çÓEßý°Çò8ãñ×Þ~KÏá5GýqÌmØ/Ž¬‡Ï<Þì6‰Ô—±.DÊ•üá´û#ë’�On(¨ÿ¿ò>¾‡ø#Þýâú¾YVV�³h¸I¶¹®  ÐtÔ A u“Cc€Â¹ƒ®ÁQ}8¹ &ÿs?‰0Í¥3‚
s4È|çz=3ù3ó¾¬êëúú»=ÊÏ¯òÔîVÀþ¤
ñ©#©Ã~ÇýUz@†
Ü’Û?†G
«?¨r�/rº–Hè¯W�uÞ×ù»šê†¦P£Æ¬>h)Ua8j]U©s–¸�b"Ò�"KýÿM˜Õ66íi-5ô"KýÿM˜Õ66íi-5öKóþ^óöüÿ—¼ý+ÏÚï?Ø8yjªš˜Ñóî>á9¯E$„ê¨ù¨ÕS¿:&oj°nQl«6Q�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�Ó0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÌØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸L¸±X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßõè©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&é¶.&|±û“‘:–Ø-“Š¾"¢›ÎÝkÝ×gÁM•"Tø>XHN^Ý¥£(ÎÞ?:½,~,�N6–Ã×3 D0¨É 3ºó¯³·‡³Œì,¬8Ã	´ííPÂYÂ›ÝÐ\ÐT]ˆMT=5PôÉU2Žª½�ï?þM·Ulsµ-ƒüteF}«ÿ�NþÈÎïŠñþ<éðgâóêïëLƒ:»díÎ$&í+�²³½Nˆ�Åÿò´ü|ã>›Â^lºõü%Ç¦Ïx4ÓÞ	tM˜�Â9Ñ+¡H ùyÃ�äQtš‚n3¸áOJ~°UD “ºÃWWß8$Âª¢£SMs4UTµo¨n«œáÎÒÅ^Ü¥ªamUë~Fú¥iU…*•µ¹Rfa%z‡J}c¥´„7æí1¸¹«+od£áïòÈ‘—œg§Ûƒý#�aŸ1ÜíðïF¦ÓY_OOÄÍ‚ø×©¼ûÛÒæ–Š<9RJÏJY*3\¢�hçCl‚-ÎË*	ƒ­­;Â¿\mC�†ÿØ¢5U0¤ï¬/¼l¢ÑIJ4Šmí‚˜4Þ6Zîž-�o%ê¸‡‚{_RÚáH˜ÃŽèü2ÖpgÌ÷dÑz•Hí¶�W+¬{µéóŠ½+—÷²7õáºÓn©êßL«€„Õ]V<ÕT”wb…žÙî¾ªÖi¡M©´
h»a0gf¡bjEVWV@+ÌÝ«üU#ß‡      �  §  *  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  !¯<?xml version="1.0"?><Features recycledIDs="1,21,0" nextValidID="22"><Feature recentID="7" name="MCS" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="901-935" color="#ccffcc" type="standard"/></Feature><Feature recentID="20" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6494" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="5703-6494" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6495-6563" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="19" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3407-4201" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="18" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1536-1538" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1539-1541" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1542-2255" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="17" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="949-1523" color="#a6acb3" type="standard"/><Segment name="ATG" range="1524-1526" color="#a6acb3" type="standard"/><Segment range="1527-1535" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4947-5532" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2569-2997" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="235-614" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3011-3340" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2299-2523" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="615-818" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3191-3326" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4375-4496" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6564-6668" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4593-4599" color="#ffffff" type="standard"/><Segment range="4600-4617" color="#ffffff" type="standard"/><Segment name="-35" range="4618-4623" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4638-4659" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="T7 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="863-881" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for bacteriophage T7 RNA polymerase&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4545-4561" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4569-4585" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  f<Notes>
<UUID>059de63e-f495-4768-a94f-65d6c943e1cf</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="1:38:26">2023.6.15</Created>
<LastModified UTC="1:44:14">2023.6.15</LastModified>
<CreatedBy>Triple Threat</CreatedBy>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
   «<StrandColors><TopStrand><ColorRange range="900..934" colors="black"/></TopStrand><BottomStrand><ColorRange range="900..934" colors="black"/></BottomStrand></StrandColors>  ,D   	  «  "        "¿þ`�îÒu¸îód¥=&ã¿ŽˆŠ,á$ŒÄÕjS�uC¡ñÖ�…ã¤
C*Œã¬Æ'Ñ™Ì¡Úhy)¥’[Zpi+dý™�+Ì§eéÂVÏƒ‡Ï×üý¡ËYaÉŠý’\õ�¯hrÖšœ%xýè4�µ"m˜õ'?ù¡ËXp•ƒóàÚcô�‡é€z¾z'nri-³š}‚Â¨4�µ€È0¨{p¯RïÚµ€JŠ ßUµÀz½V,—^óý¡ÍX$2'.fSDîàåäEýã§ƒ¦ÅigÞdSƒ“9éOH0ó±kóþïïÿÿ—)àñO:”<"2¢æbš¯}š<º Ö!ðWàþ.ºM¯�«þìõAcP¸¡bÈPSJû�NºuuË‰1þ£CLÿßƒûŒ=T÷"eß�PÃuÿH÷(„ d¢Dµ`îûS&µÔ…?E	ÿh˜á¸ì#v:�ˆ©,B•UË�ÿñ}À‚«ê]ÆfuöM@ÄŠß ‚?o‚ÄàpÇ%p÷R´È¼11�~pÔáþ­¸ß|58ü�àýþÈ}þœ24Ž´óŸñ÷aM7ºÔ¼ö?9ËÐLßnºÔp×�Gó<B¬@Ç‚Í±8P6Ç­Avøu8uç]=×.fØ<u4QpÛP…ëQ¼÷]±24ìñ÷ŸMöÃ?Èã�Ç_yøMý/?„ÕõÄS1·`¾8²<ð{°ØN'R^Ä¹?*Wó†Óìx�®J==¸¢£þÿÈúúàP�{÷‹êùeXAZ6Í¢á$"Úæ¸  AÓP€QÖMŽ cæ¸CEôàä ›ýÌþ$Ã6”Ì0")ÌÓ!ó�èôÏäÏÎú³«¯ëêì÷+<:¿ËS¹[ ;ú�+Æ¤Ž§ûõUèi+rHlþ*¬þ¡Ê½ÊêY {¢½^×{_æì.kª™@j�°ù ¥U„á©uV¥ÌZZâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ¸û„æ½’Cª Cä:£UNüè™½ªÁ¸mDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^4CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíC3cñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?×¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¦Ø¸™òÇîNDè2[`¶N*øˆVŠo;u¯w]œO6T‰Sàùa!9{v–Œ£;xüêô°ø²=8ÚX[\ÌÂ£&€ÎëÎ¾ÎÞÎ3°²°ãL&Ó·µC	g
ot[@sAQv!5PôÕCÐ_%T<Ê82ªöC¼ÿøq6ÝU±ÎÔ´BWñÐy•ô2¯þ;û#;¾+Çøó§ÁŸ‹Ï«¿¬2êí“·8�›´¬"BÊÎõ8"7ÿÊÓñóŒúo	y²èK×ð”w›=àÓOx%Ði4LBbCçD®… ƒåçw‘EÒj	¸Îã…=)úÁU‚Nèo]_|à“
ªŠ�M4iÌÑUPnÔQ¾¡º®p‡;H{r”¨-„iµT­ùê•¥VªVÖåI™„•è.)õŽ–Òß›´Æâæ¬­½’�‡¿Ë"F^qœŸnôŽ5†|Äs·Ã½›Me}=<4Rã^¦óïoKšZ(ðäII+=)d¨ÍrŠ=£�²·;,¨&¶´ï
ýqµJvÿbˆÕTÂ“¾°¾ñ²‹E%(<Ò)·¶
`ÓxÙkºx¶=¼”cªâIí}Kk„Y"c|J;£ðËYÀeŸ3Ý“EêU#¶Ú\®°UîÔ§Î(Fô¬b_ÞÈß×†ëMº§«}2®Ut5XóUPP1ÜŠ{gºú«Y¦…6¦Ð)¢í„Á�š…‰©Y]Y ¯3v¯ñT�~      �  ž  !  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  !¯<?xml version="1.0"?><Features recycledIDs="1,21,0" nextValidID="22"><Feature recentID="7" name="MCS" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="901-926" color="#ccffcc" type="standard"/></Feature><Feature recentID="20" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6485" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="5694-6485" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6486-6554" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="19" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3398-4192" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="18" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1527-1529" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1530-1532" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1533-2246" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="17" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="940-1514" color="#a6acb3" type="standard"/><Segment name="ATG" range="1515-1517" color="#a6acb3" type="standard"/><Segment range="1518-1526" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4938-5523" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2560-2988" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="235-614" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3002-3331" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2290-2514" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="615-818" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3182-3317" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4366-4487" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6555-6659" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4584-4590" color="#ffffff" type="standard"/><Segment range="4591-4608" color="#ffffff" type="standard"/><Segment name="-35" range="4609-4614" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4629-4650" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="T7 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="863-881" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for bacteriophage T7 RNA polymerase&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4536-4552" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4560-4576" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  e<Notes>
<UUID>059de63e-f495-4768-a94f-65d6c943e1cf</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="1:38:26">2023.6.15</Created>
<LastModified UTC="1:44:3">2023.6.15</LastModified>
<CreatedBy>Triple Threat</CreatedBy>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
   «<StrandColors><TopStrand><ColorRange range="900..925" colors="black"/></TopStrand><BottomStrand><ColorRange range="900..925" colors="black"/></BottomStrand></StrandColors>  ,G     ­  +        +¿þ`�îÒu¸îód¥=&ã¿ŽˆŠ,á$ŒÄÕjS�uC¡ñÖ�…ã¤
C*Œã¬Æ'Ñ™Ì¡Úhy)¥’[Zpi+dý™�+Ì§eéÂVÏƒ‡Ï×üý¡ËYaÉŠý’\õ�¯hrÖšœ%xýè4�µ"m˜õ'?ù¡ËXp•ƒóàÚcô�‡é€z¾z'nri-³š}‚Â¨4�µ€È0¨{p¯RïÚµ€JŠ ßUµÀz½V,—^óý¡ÍX$2'.fSDîàåäEýã§ƒ¦ÅigÞdSƒ“9éLÑ›Ò<ìZÁ¼ÿ»ûÿÿåÊx<SÎ�eŒ¨¹˜¦«ßf�.¨5ˆ@üø?‹®‡käêÿ»=PXÔ.(X²Ò¾àS®…]râL¨ÐÓÿ÷àÇB>ãU=È™FwãT0ÝÒ=Ê!((�Q-X;¾ÔÉ­u áA�ÑBÚ&¸n ûÝŽ§b*K¥Urä?ü_p ªú…Wq†YƒÝ}‚P1â·À �Ûà±81É\=Ô­2/@Äcßœ58…+n7ßN?#ø?²‡ç�#­<çü}ØSMÇ®µ/=�Årô7Û®µ5çQüÏ…+1ßà…ólN±ëPAÃ]¾ ÝN�y×OuË™¶M\6Ô!zÔo=×lAÃL�;<}çÓEßý°Çò8ãñ×Þ~KÏá5GýqÌmØ/Ž¬‡Ï<Þì6‰Ô—±.DÊ•üá´û#ë’�On(¨ÿ¿ò>¾‡ø#Þýâú¾YVV�³h¸I¶¹®  ÐtÔ A u“Cc€Â¹ƒ®ÁQ}8¹ &ÿs?‰0Í¥3‚
s4È|çz=3ù3ó¾¬êëúú»=ÊÏ¯òÔîVÀþ¤
ñ©#©Ã~ÇýUz@†
Ü’Û?†G
«?¨r�/rº–Hè¯W�uÞ×ù»šê†¦P£Æ¬>h)Ua8j]U©s–¸�b"Ò�"KýÿM˜Õ66íi-5ô"KýÿM˜Õ66íi-5öKóþ^óöüÿ—¼ý+ÏÚï?Ø8yjªš˜Ñóî>á9¯E$„ê¨ù¨ÕS¿:&oj°nQl«6Q�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�Ó0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÌØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸L¸±X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßõè©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&é¶.&|±û“‘:–Ø-“Š¾"¢›ÎÝkÝ×gÁM•"Tø>XHN^Ý¥£(ÎÞ?:½,~,�N6–Ã×3 D0¨É 3ºó¯³·‡³Œì,¬8Ã	´ííPÂYÂ›ÝÐ\ÐT]ˆMT=5PôÉU2Žª½�ï?þM·Ulsµ-ƒüteF}«ÿ�NþÈÎïŠñþ<éðgâóêïëLƒ:»díÎ$&í+�²³½Nˆ�Åÿò´ü|ã>›Â^lºõü%Ç¦Ïx4ÓÞ	tM˜�Â9Ñ+¡H ùyÃ�äQtš‚n3¸áOJ~°UD “ºÃWWß8$Âª¢£SMs4UTµo¨n«œáÎÒÅ^Ü¥ªamUë~Fú¥iU…*•µ¹Rfa%z‡J}c¥´„7æí1¸¹«+od£áïòÈ‘—œg§Ûƒý#�aŸ1ÜíðïF¦ÓY_OOÄÍ‚ø×©¼ûÛÒæ–Š<9RJÏJY*3\¢�hçCl‚-ÎË*	ƒ­­;Â¿\mC�†ÿØ¢5U0¤ï¬/¼l¢ÑIJ4Šmí‚˜4Þ6Zîž-�o%ê¸‡‚{_RÚáH˜ÃŽèü2ÖpgÌ÷dÑz•Hí¶�W+¬{µéóŠ½+—÷²7õáºÓn©êßL«€„Õ]V<ÕT”wb…žÙî¾ªÖi¡M©´
h»a0gf¡bjEVWV@+ÌÝ«üU#ß‡      �  §  *  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  !¯<?xml version="1.0"?><Features recycledIDs="1,21,0" nextValidID="22"><Feature recentID="7" name="MCS" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="901-935" color="#ccffcc" type="standard"/></Feature><Feature recentID="20" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6494" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="5703-6494" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6495-6563" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="19" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3407-4201" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="18" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1536-1538" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1539-1541" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1542-2255" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="17" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="949-1523" color="#a6acb3" type="standard"/><Segment name="ATG" range="1524-1526" color="#a6acb3" type="standard"/><Segment range="1527-1535" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4947-5532" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2569-2997" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="235-614" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3011-3340" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2299-2523" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="615-818" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3191-3326" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4375-4496" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6564-6668" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4593-4599" color="#ffffff" type="standard"/><Segment range="4600-4617" color="#ffffff" type="standard"/><Segment name="-35" range="4618-4623" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4638-4659" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="T7 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="863-881" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for bacteriophage T7 RNA polymerase&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4545-4561" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4569-4585" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  f<Notes>
<UUID>059de63e-f495-4768-a94f-65d6c943e1cf</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="1:38:26">2023.6.15</Created>
<LastModified UTC="1:43:59">2023.6.15</LastModified>
<CreatedBy>Triple Threat</CreatedBy>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
   «<StrandColors><TopStrand><ColorRange range="900..934" colors="black"/></TopStrand><BottomStrand><ColorRange range="900..934" colors="black"/></BottomStrand></StrandColors>  ,H     ®  -        -¿þ`�îÒu¸îód¥=&ã¿ŽˆŠ,á$ŒÄÕjS�uC¡ñÖ�…ã¤
C*Œã¬Æ'Ñ™Ì¡Úhy)¥’[Zpi+dý™�+Ì§eéÂVÏƒ‡Ï×üý¡ËYaÉŠý’\õ�¯hrÖšœ%xýè4�µ"m˜õ'?ù¡ËXp•ƒóàÚcô�‡é€z¾z'nri-³š}‚Â¨4�µ€È0¨{p¯RïÚµ€JŠ ßUµÀz½V,—^óý¡ÍX$2'.fSDîàåäEýã§ƒ¦ÅigÞdSƒ“9éO�½ ÃÎÅ¬Ïû¿¿ÿþ\§ƒÅ<èPðˆÊ‹™Šj½öhòêƒX„Á_ƒøºèq6¾@.¯û³Õ�Bâ…‹!AM+î:èQÕ×.$Çú�0_ÿ~t#î0õSÜ‰”g~5C×ý#Ü¢�’ˆÕƒ»íLš×Pý'ý¢`†à°�Øêv"¤±
UW.CÿÅ÷ r
¯¨Uwe˜=×Ø!5N+|ý¾�Ã•ÃÝJÓ"ðÄ@Æ=ùÃS‡øR¶ã}ðÔãò?ƒ÷û!÷ø~pÈÒ:ÓÎÇÝ…4ÜzëRóØüPç/A3}ºëPqÃ^uÌñR±þ_6Äá@Ûµ5ÛàÔàI×�t÷\¹›`ñÔÑEÃmB­FóÝvÄ4ÈÓ³ÇÞ}4]ÿÛpÿ#Ž?}çá7ô¼þT×LÆÝ‚øàJÈ|óÀmîÃ`q8�I{ä@ü©_ÎO±â>¹(ôöâŠ�ûÿ#ëè�B=ïÞ/«å•ahÛ6‹„�‹kšà € M@GY468Œ ;˜:áÓ€;�o÷3ø“ÚS0Àˆ §3L‡Îw£Ó?“?;êÎ®¿¯«³Ü¬ðêÿ-Nål ïê@¯’:œ7ìÕW¡¤`­É =³ødpª³ú‡(÷+©d�îŠõx]í›°¹®¨jeª<jÃæ‚•V†¥ÕZ—1ikˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ãîšôRHAª��ê�U;ð¢fö«áµÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÐq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµÍ�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýÿ^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn›bâgË¹9 Ém‚Ù8«â!Z)¼íÖ½Ývq<ÙR%O€#å„„åíÚZ2Œíãó«ÒÀWâÈôãial=s0C
Œš;¯:û;x{8ÎÂÊÃŒ10›NÞÕ%œ)½Ñm eÍEØ„ÕCÓUA|•Pó(àÊ«ÙóÿáÄÛuVÇ;RÑ1_ÇAæTgÐÊ¿øïìŒîø¯ãÎŸ~/>®þ°È3«¶NÜâBnÒ°‰+;Ôà8ˆÜ_ÿ+OÇÎ3é¼%æË¡/_ÂQÜzl÷ƒM=à—A¤Ñ1	‰#�º‚—œ9ÞEI¨&ã;Žô§ëTJ	;¡¼5u}ó‚L*ª*54Ñ§3EUA»QFú†ê¹À.í \UíÊP ¶¦ÕPn·äoªV•XR©[[•&fW ¸t§Ö:[HC~nÓ‹š²¶öJ>ÿ,‰yÆp:}¸?Ò8ÖóýÎßôjm5•ôôðP<LÑH/�z›Ï½½.ih£ÀS‘%$¬ô¥’£5Ê(öŽt6È"Üì² ˜:ÚÓ¼+õÆÔ1)ØoýŠ#US
NúÂûÆÊ-” óH¦ÞØ)ƒMãe®éâØöòQŽ«ˆx!'µõ-®d‰Œ1ñ(î�Ã-g–|ÏvM©TŽÛhrºÀ1W»PnŸ8¡Ò±‰{#^­6êž­ôÊ¸MUÐPÕcÍU@Y@ÇpV(Yížëê­fšÚ›@¦‹¶vj&¤Ueud¼ÍÚ¿ÅR=ør      �  ©  ,  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  !¯<?xml version="1.0"?><Features recycledIDs="1,21,0" nextValidID="22"><Feature recentID="7" name="MCS" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="901-937" color="#ccffcc" type="standard"/></Feature><Feature recentID="20" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6496" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="5705-6496" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6497-6565" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="19" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3409-4203" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="18" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1538-1540" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1541-1543" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1544-2257" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="17" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="951-1525" color="#a6acb3" type="standard"/><Segment name="ATG" range="1526-1528" color="#a6acb3" type="standard"/><Segment range="1529-1537" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4949-5534" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2571-2999" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="235-614" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3013-3342" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2301-2525" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="615-818" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3193-3328" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4377-4498" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6566-6670" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4595-4601" color="#ffffff" type="standard"/><Segment range="4602-4619" color="#ffffff" type="standard"/><Segment name="-35" range="4620-4625" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4640-4661" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="T7 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="863-881" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for bacteriophage T7 RNA polymerase&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4547-4563" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4571-4587" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  f<Notes>
<UUID>059de63e-f495-4768-a94f-65d6c943e1cf</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="1:38:26">2023.6.15</Created>
<LastModified UTC="1:43:41">2023.6.15</LastModified>
<CreatedBy>Triple Threat</CreatedBy>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
   «<StrandColors><TopStrand><ColorRange range="900..936" colors="black"/></TopStrand><BottomStrand><ColorRange range="900..936" colors="black"/></BottomStrand></StrandColors>  ,K     ±  <        <¿þ`�îÒu¸îód¥=&ã¿ŽˆŠ,á$ŒÄÕjS�uC¡ñÖ�…ã¤
C*Œã¬Æ'Ñ™Ì¡Úhy)¥’[Zpi+dý™�+Ì§eéÂVÏƒ‡Ï×üý¡ËYaÉŠý’\õ�¯hrÖšœ%xýè4�µ"m˜õ'?ù¡ËXp•ƒóàÚcô�‡é€z¾z'nri-³š}‚Â¨4�µ€È0¨{p¯RïÚµ€JŠ ßUµÀz½V,—^óý¡ÍX$2'.fSDîàåäEýã§ƒ¦ÅigÞdSƒ“9éO�½ ÃÎÄ¹?°o?îþÿÿùržó YCÂ#*.f)ª÷Ù£Ëªb?~âë¡ÄÚù º¿îÏT5Š,…4¯¸ë¡GW\¸“ê44Áýø1Ð�¸ÃÕOr&Q�øÕ7_ô�rˆJJ TKVïµ2k]@8PcôPŸö‰€n€>Â7c©ØŠ’Ä)U\¹ÿÜÈ*¾¡UÜa–`÷_`„ÔA8­ð#öø,NrWu+L‹Ã1÷çNáJÛ�÷ÃS�Èþßì‡ßáùÃ#HëO9ÿvÓqë­KÏcñCœ½Íöë­AÇyÔ3Ä!JÄwø!|Û…lzÔp×o€7S�'^uÓÝræmƒÇSEµ^µÏuÛpÓ#NÏyôÑwÿl1ÃüŽ8üu÷Ÿ„ßÒóøMQÿ\E3vã�+!óÏ·»�Äâu%ìK‘ò¥8m>Çˆúä£ÓÛŠ*?ïü�¯¡þ÷¿x¾¯–U„£lÚ.B-®k€ €45 hdÐØà0€î`ë„0T_N î@	¿ÜÏâL3iLÃ ‚œÍ29Þ�LþLüï«:ºþ¾®Ïr³Ã«üµ;•°¿©¼jHêpß±ÿU^†�!‚·$€öÏá‘ÂªÏê KÜ®¥’º+Õà]wµþnÂæº¡©”¨ñ«š
UXN—Uj\Å¥® Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û�¸NkÑI!:ª>Cª5TïÀN‰›Ú¬†ÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãAÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô36?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬VSý~=·«÷Ï>¹…B€ë²«ÀsÃ�†ûÓ0íŽ®³÷ýz*hÓ¦X)Õ•5“mÕ«ueMª«xÚä¢
‹Õíµ‰ºm‹‰Ÿ,~ääNƒ%¶dâ¯ˆ…h¦ó·Z÷uÙÄðSeH•> �–—·ihÊ3·�Î¯K_‹#Ó�¥…°õÌÀ*2hî¼ëìíáìã;+0ÄÂm;{T0–p¦÷E´—4bUMT=òUCÌ£ƒ*¯d;Ïÿ‡mÕ[íKD Å™QŸC*ÿàS¿²3»â¼�:|ø¼ú»úÀS Î®Ù;s‰	»JÂ$,¬ïS€â#qü­?8Ï¦ð—›.„½	Gqé³Þ4÷‚]“DÄ&$0ŽtJèR>^pçy]& ›Œî8SÒŸ¬Q($î†ðÕÕ÷Î	0ª¨¨ÔÓFœÍUíEêªç ¸s´�qW·)@j‚ØF›UAºß‘¾©ZUaJ¥mnT™˜I^‚áÒŸXém!ù»Ln.jÊÛÙ(ø{ü²$eçÀ@éöàÿHãXgÌG÷;|;Ñ©´ÖWÓÓÁ@ñ3E ¾5êo>öô¹¥¢�ND”’³Ò–JŒ×(£Ú9ÐÛ ‹s²Ê‚`ëkNð¯×PÄ§a¿ö(�UL);ëï(´RRƒÍ"›{`¦7�–»§‹cÛÉF:®!à„ž×Ô¶¸E’&0ÇÄ£º?µœYó=Ù4^¥R;m UÊë Å^íAº|â„oJÆ%ýì�ýxn´Ûªz·Ó*à!5WACU�5UeÁX¡g¶{¯ªµšhSjmš.ØLÙ¨Xš‘U•Õ�
ó7jÿH÷áË      �  ¸  ;  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  !¯<?xml version="1.0"?><Features recycledIDs="1,21,0" nextValidID="22"><Feature recentID="7" name="MCS" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="901-952" color="#ccffcc" type="standard"/></Feature><Feature recentID="20" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6511" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="5720-6511" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6512-6580" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="19" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3424-4218" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="18" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1553-1555" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1556-1558" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1559-2272" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="17" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="966-1540" color="#a6acb3" type="standard"/><Segment name="ATG" range="1541-1543" color="#a6acb3" type="standard"/><Segment range="1544-1552" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4964-5549" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2586-3014" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="235-614" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3028-3357" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2316-2540" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="615-818" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3208-3343" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4392-4513" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6581-6685" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4610-4616" color="#ffffff" type="standard"/><Segment range="4617-4634" color="#ffffff" type="standard"/><Segment name="-35" range="4635-4640" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4655-4676" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="T7 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="863-881" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for bacteriophage T7 RNA polymerase&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4562-4578" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4586-4602" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  f<Notes>
<UUID>059de63e-f495-4768-a94f-65d6c943e1cf</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="1:38:26">2023.6.15</Created>
<LastModified UTC="1:43:29">2023.6.15</LastModified>
<CreatedBy>Triple Threat</CreatedBy>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
   «<StrandColors><TopStrand><ColorRange range="900..951" colors="black"/></TopStrand><BottomStrand><ColorRange range="900..951" colors="black"/></BottomStrand></StrandColors>  ,M     ³  A        A¿þ`�îÒu¸îód¥=&ã¿ŽˆŠ,á$ŒÄÕjS�uC¡ñÖ�…ã¤
C*Œã¬Æ'Ñ™Ì¡Úhy)¥’[Zpi+dý™�+Ì§eéÂVÏƒ‡Ï×üý¡ËYaÉŠý’\õ�¯hrÖšœ%xýè4�µ"m˜õ'?ù¡ËXp•ƒóàÚcô�‡é€z¾z'nri-³š}‚Â¨4�µ€È0¨{p¯RïÚµ€JŠ ßUµÀz½V,—^óý¡ÍX$2'.fSDîàåäEýã§ƒ¦ÅigÞdSƒ“9éO�½7H0ó±.DÅ¬Ïû¿¿ÿþ\§ƒÅ<èPðˆÊ‹™Šj½öhòêƒX„Á_ƒøºèq6¾@.¯û³Õ�Bâ…‹!AM+î:èQÕ×.$Çú�0_ÿ~t#î0õSÜ‰”g~5C×ý#Ü¢�’ˆÕƒ»íLš×Pý'ý¢`†à°�Øêv"¤±
UW.CÿÅ÷ r
¯¨Uwe˜=×Ø!5N+|ý¾�Ã•ÃÝJÓ"ðÄ@Æ=ùÃS‡øR¶ã}ðÔãò?ƒ÷û!÷ø~pÈÒ:ÓÎÇÝ…4ÜzëRóØüPç/A3}ºëPqÃ^uÌñR±þ_6Äá@Ûµ5ÛàÔàI×�t÷\¹›`ñÔÑEÃmB­FóÝvÄ4ÈÓ³ÇÞ}4]ÿÛpÿ#Ž?}çá7ô¼þT×LÆÝ‚øàJÈ|óÀmîÃ`q8�I{ä@ü©_ÎO±â>¹(ôöâŠ�ûÿ#ëè�B=ïÞ/«å•ahÛ6‹„�‹kšà € M@GY468Œ ;˜:áÓ€;�o÷3ø“ÚS0Àˆ §3L‡Îw£Ó?“?;êÎ®¿¯«³Ü¬ðêÿ-Nål ïê@¯’:œ7ìÕW¡¤`­É =³ødpª³ú‡(÷+©d�îŠõx]í›°¹®¨jeª<jÃæ‚•V†¥ÕZ—1ikˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ãîšôRHAª��ê�U;ð¢fö«áµÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÐq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµÍ�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýÿ^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn›bâgË¹9 Ém‚Ù8«â!Z)¼íÖ½Ývq<ÙR%O€#å„„åíÚZ2Œíãó«ÒÀWâÈôãial=s0C
Œš;¯:û;x{8ÎÂÊÃŒ10›NÞÕ%œ)½Ñm eÍEØ„ÕCÓUA|•Pó(àÊ«ÙóÿáÄÛuVÇ;RÑ1_ÇAæTgÐÊ¿øïìŒîø¯ãÎŸ~/>®þ°È3«¶NÜâBnÒ°‰+;Ôà8ˆÜ_ÿ+OÇÎ3é¼%æË¡/_ÂQÜzl÷ƒM=à—A¤Ñ1	‰#�º‚—œ9ÞEI¨&ã;Žô§ëTJ	;¡¼5u}ó‚L*ª*54Ñ§3EUA»QFú†ê¹À.í \UíÊP ¶¦ÕPn·äoªV•XR©[[•&fW ¸t§Ö:[HC~nÓ‹š²¶öJ>ÿ,‰yÆp:}¸?Ò8ÖóýÎßôjm5•ôôðP<LÑH/�z›Ï½½.ih£ÀS‘%$¬ô¥’£5Ê(öŽt6È"Üì² ˜:ÚÓ¼+õÆÔ1)ØoýŠ#US
NúÂûÆÊ-” óH¦ÞØ)ƒMãe®éâØöòQŽ«ˆx!'µõ-®d‰Œ1ñ(î�Ã-g–|ÏvM©TŽÛhrºÀ1W»PnŸ8¡Ò±‰{#^­6êž­ôÊ¸MUÐPÕcÍU@Y@ÇpV(Yížëê­fšÚ›@¦‹¶vj&¤Ueud¼ÍÚ¿ÅR=ør      �  ½  @  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  !¯<?xml version="1.0"?><Features recycledIDs="1,21,0" nextValidID="22"><Feature recentID="7" name="MCS" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="901-957" color="#ccffcc" type="standard"/></Feature><Feature recentID="20" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6516" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="5725-6516" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6517-6585" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="19" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3429-4223" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="18" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1558-1560" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1561-1563" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1564-2277" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="17" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="971-1545" color="#a6acb3" type="standard"/><Segment name="ATG" range="1546-1548" color="#a6acb3" type="standard"/><Segment range="1549-1557" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4969-5554" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2591-3019" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="235-614" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3033-3362" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2321-2545" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="615-818" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3213-3348" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4397-4518" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6586-6690" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4615-4621" color="#ffffff" type="standard"/><Segment range="4622-4639" color="#ffffff" type="standard"/><Segment name="-35" range="4640-4645" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4660-4681" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="T7 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="863-881" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for bacteriophage T7 RNA polymerase&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4567-4583" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4591-4607" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  f<Notes>
<UUID>059de63e-f495-4768-a94f-65d6c943e1cf</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="1:38:26">2023.6.15</Created>
<LastModified UTC="1:43:24">2023.6.15</LastModified>
<CreatedBy>Triple Threat</CreatedBy>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
   «<StrandColors><TopStrand><ColorRange range="900..956" colors="black"/></TopStrand><BottomStrand><ColorRange range="900..956" colors="black"/></BottomStrand></StrandColors>  ,X     ½  k        k¿þ`�îÒu¸îód¥=&ã¿ŽˆŠ,á$ŒÄÕjS�uC¡ñÖ�…ã¤
C*Œã¬Æ'Ñ™Ì¡Úhy)¥’[Zpi+dý™�+Ì§eéÂVÏƒ‡Ï×üý¡ËYaÉŠý’\õ�¯hrÖšœ%xýè4�µ"m˜õ'?ù¡ËXp•ƒóàÚcô�‡é€z¾z'nri-³š}‚Â¨4�µ€È0¨{p¯RïÚµ€JŠ ßUµÀz½V,—^óý¡ÍX$2'.fSDîàåäEýã§ƒ¦ÅigÞdSƒ“9éN‚|NÁ½ä½"¸Ñ›Ótƒ;ä@üZÁ¼ÿ»ûÿÿåÊx<SÎ�eŒ¨¹˜¦«ßf�.¨5ˆ@üø?‹®‡käêÿ»=PXÔ.(X²Ò¾àS®…]râL¨ÐÓÿ÷àÇB>ãU=È™FwãT0ÝÒ=Ê!((�Q-X;¾ÔÉ­u áA�ÑBÚ&¸n ûÝŽ§b*K¥Urä?ü_p ªú…Wq†YƒÝ}‚P1â·À �Ûà±81É\=Ô­2/@Äcßœ58…+n7ßN?#ø?²‡ç�#­<çü}ØSMÇ®µ/=�Årô7Û®µ5çQüÏ…+1ßà…ólN±ëPAÃ]¾ ÝN�y×OuË™¶M\6Ô!zÔo=×lAÃL�;<}çÓEßý°Çò8ãñ×Þ~KÏá5GýqÌmØ/Ž¬‡Ï<Þì6‰Ô—±.DÊ•üá´û#ë’�On(¨ÿ¿ò>¾‡ø#Þýâú¾YVV�³h¸I¶¹®  ÐtÔ A u“Cc€Â¹ƒ®ÁQ}8¹ &ÿs?‰0Í¥3‚
s4È|çz=3ù3ó¾¬êëúú»=ÊÏ¯òÔîVÀþ¤
ñ©#©Ã~ÇýUz@†
Ü’Û?†G
«?¨r�/rº–Hè¯W�uÞ×ù»šê†¦P£Æ¬>h)Ua8j]U©s–¸�b"Ò�"KýÿM˜Õ66íi-5ô"KýÿM˜Õ66íi-5öKóþ^óöüÿ—¼ý+ÏÚï?Ø8yjªš˜Ñóî>á9¯E$„ê¨ù¨ÕS¿:&oj°nQl«6Q�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�Ó0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÌØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸L¸±X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßõè©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&é¶.&|±û“‘:–Ø-“Š¾"¢›ÎÝkÝ×gÁM•"Tø>XHN^Ý¥£(ÎÞ?:½,~,�N6–Ã×3 D0¨É 3ºó¯³·‡³Œì,¬8Ã	´ííPÂYÂ›ÝÐ\ÐT]ˆMT=5PôÉU2Žª½�ï?þM·Ulsµ-ƒüteF}«ÿ�NþÈÎïŠñþ<éðgâóêïëLƒ:»díÎ$&í+�²³½Nˆ�Åÿò´ü|ã>›Â^lºõü%Ç¦Ïx4ÓÞ	tM˜�Â9Ñ+¡H ùyÃ�äQtš‚n3¸áOJ~°UD “ºÃWWß8$Âª¢£SMs4UTµo¨n«œáÎÒÅ^Ü¥ªamUë~Fú¥iU…*•µ¹Rfa%z‡J}c¥´„7æí1¸¹«+od£áïòÈ‘—œg§Ûƒý#�aŸ1ÜíðïF¦ÓY_OOÄÍ‚ø×©¼ûÛÒæ–Š<9RJÏJY*3\¢�hçCl‚-ÎË*	ƒ­­;Â¿\mC�†ÿØ¢5U0¤ï¬/¼l¢ÑIJ4Šmí‚˜4Þ6Zîž-�o%ê¸‡‚{_RÚáH˜ÃŽèü2ÖpgÌ÷dÑz•Hí¶�W+¬{µéóŠ½+—÷²7õáºÓn©êßL«€„Õ]V<ÕT”wb…žÙî¾ªÖi¡M©´
h»a0gf¡bjEVWV@+ÌÝ«üU#ß‡      �  ç  j  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  !°<?xml version="1.0"?><Features recycledIDs="1,21,0" nextValidID="22"><Feature recentID="7" name="MCS" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="901-999" color="#ccffcc" type="standard"/></Feature><Feature recentID="20" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6558" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="5767-6558" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6559-6627" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="19" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3471-4265" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="18" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1600-1602" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1603-1605" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1606-2319" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="17" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1013-1587" color="#a6acb3" type="standard"/><Segment name="ATG" range="1588-1590" color="#a6acb3" type="standard"/><Segment range="1591-1599" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5011-5596" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2633-3061" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="235-614" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3075-3404" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2363-2587" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="615-818" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3255-3390" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4439-4560" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6628-6732" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4657-4663" color="#ffffff" type="standard"/><Segment range="4664-4681" color="#ffffff" type="standard"/><Segment name="-35" range="4682-4687" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4702-4723" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="T7 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="863-881" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for bacteriophage T7 RNA polymerase&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4609-4625" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4633-4649" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  f<Notes>
<UUID>059de63e-f495-4768-a94f-65d6c943e1cf</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="1:38:26">2023.6.15</Created>
<LastModified UTC="1:43:20">2023.6.15</LastModified>
<CreatedBy>Triple Threat</CreatedBy>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
   «<StrandColors><TopStrand><ColorRange range="900..998" colors="black"/></TopStrand><BottomStrand><ColorRange range="900..998" colors="black"/></BottomStrand></StrandColors>  ,]     ¿  t        t¿þ`�îÒu¸îód¥=&ã¿ŽˆŠ,á$ŒÄÕjS�uC¡ñÖ�…ã¤
C*Œã¬Æ'Ñ™Ì¡Úhy)¥’[Zpi+dý™�+Ì§eéÂVÏƒ‡Ï×üý¡ËYaÉŠý’\õ�¯hrÖšœ%xýè4�µ"m˜õ'?ù¡ËXp•ƒóàÚcô�‡é€z¾z'nri-³š}‚Â¨4�µ€È0¨{p¯RïÚµ€JŠ ßUµÀz½V,—^óý¡ÍX$2'.fSDîàåäEýã§ƒ¦ÅigÞdSƒ“92¥zS Ÿ°oy/H‚®4fôÝ ÃÎÄ¹?°o?îþÿÿùržó YCÂ#*.f)ª÷Ù£Ëªb?~âë¡ÄÚù º¿îÏT5Š,…4¯¸ë¡GW\¸“ê44Áýø1Ð�¸ÃÕOr&Q�øÕ7_ô�rˆJJ TKVïµ2k]@8PcôPŸö‰€n€>Â7c©ØŠ’Ä)U\¹ÿÜÈ*¾¡UÜa–`÷_`„ÔA8­ð#öø,NrWu+L‹Ã1÷çNáJÛ�÷ÃS�Èþßì‡ßáùÃ#HëO9ÿvÓqë­KÏcñCœ½Íöë­AÇyÔ3Ä!JÄwø!|Û…lzÔp×o€7S�'^uÓÝræmƒÇSEµ^µÏuÛpÓ#NÏyôÑwÿl1ÃüŽ8üu÷Ÿ„ßÒóøMQÿ\E3vã�+!óÏ·»�Äâu%ìK‘ò¥8m>Çˆúä£ÓÛŠ*?ïü�¯¡þ÷¿x¾¯–U„£lÚ.B-®k€ €45 hdÐØà0€î`ë„0T_N î@	¿ÜÏâL3iLÃ ‚œÍ29Þ�LþLüï«:ºþ¾®Ïr³Ã«üµ;•°¿©¼jHêpß±ÿU^†�!‚·$€öÏá‘ÂªÏê KÜ®¥’º+Õà]wµþnÂæº¡©”¨ñ«š
UXN—Uj\Å¥® Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û�¸NkÑI!:ª>Cª5TïÀN‰›Ú¬†ÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãAÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô36?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬VSý~=·«÷Ï>¹…B€ë²«ÀsÃ�†ûÓ0íŽ®³÷ýz*hÓ¦X)Õ•5“mÕ«ueMª«xÚä¢
‹Õíµ‰ºm‹‰Ÿ,~ääNƒ%¶dâ¯ˆ…h¦ó·Z÷uÙÄðSeH•> �–—·ihÊ3·�Î¯K_‹#Ó�¥…°õÌÀ*2hî¼ëìíáìã;+0ÄÂm;{T0–p¦÷E´—4bUMT=òUCÌ£ƒ*¯d;Ïÿ‡mÕ[íKD Å™QŸC*ÿàS¿²3»â¼�:|ø¼ú»úÀS Î®Ù;s‰	»JÂ$,¬ïS€â#qü­?8Ï¦ð—›.„½	Gqé³Þ4÷‚]“DÄ&$0ŽtJèR>^pçy]& ›Œî8SÒŸ¬Q($î†ðÕÕ÷Î	0ª¨¨ÔÓFœÍUíEêªç ¸s´�qW·)@j‚ØF›UAºß‘¾©ZUaJ¥mnT™˜I^‚áÒŸXém!ù»Ln.jÊÛÙ(ø{ü²$eçÀ@éöàÿHãXgÌG÷;|;Ñ©´ÖWÓÓÁ@ñ3E ¾5êo>öô¹¥¢�ND”’³Ò–JŒ×(£Ú9ÐÛ ‹s²Ê‚`ëkNð¯×PÄ§a¿ö(�UL);ëï(´RRƒÍ"›{`¦7�–»§‹cÛÉF:®!à„ž×Ô¶¸E’&0ÇÄ£º?µœYó=Ù4^¥R;m UÊë Å^íAº|â„oJÆ%ýì�ýxn´Ûªz·Ó*à!5WACU�5UeÁX¡g¶{¯ªµšhSjmš.ØLÙ¨Xš‘U•Õ�
ó7jÿH÷áË      �  ð  s  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  !±<?xml version="1.0"?><Features recycledIDs="1,21,0" nextValidID="22"><Feature recentID="7" name="MCS" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="901-1008" color="#ccffcc" type="standard"/></Feature><Feature recentID="20" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6567" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="5776-6567" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6568-6636" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="19" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3480-4274" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="18" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1609-1611" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1612-1614" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1615-2328" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="17" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1022-1596" color="#a6acb3" type="standard"/><Segment name="ATG" range="1597-1599" color="#a6acb3" type="standard"/><Segment range="1600-1608" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5020-5605" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2642-3070" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="235-614" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3084-3413" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2372-2596" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="615-818" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3264-3399" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4448-4569" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6637-6741" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4666-4672" color="#ffffff" type="standard"/><Segment range="4673-4690" color="#ffffff" type="standard"/><Segment name="-35" range="4691-4696" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4711-4732" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="T7 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="863-881" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for bacteriophage T7 RNA polymerase&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4618-4634" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4642-4658" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  f<Notes>
<UUID>059de63e-f495-4768-a94f-65d6c943e1cf</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="1:38:26">2023.6.15</Created>
<LastModified UTC="1:43:16">2023.6.15</LastModified>
<CreatedBy>Triple Threat</CreatedBy>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
   ­<StrandColors><TopStrand><ColorRange range="900..1007" colors="black"/></TopStrand><BottomStrand><ColorRange range="900..1007" colors="black"/></BottomStrand></StrandColors>  *Û     ¦          ¿þ`�îÒu¸îód¥=&ã¿ŽˆŠ,á$ŒÄÕjS�uC¡ñÖ�…ã¤
C*Œã¬Æ'Ñ™Ì¡Úhy)¥’[Zpi+dý™�+Ì§eéÂVÏƒ‡Ï×üý¡ËYaÉŠý’\õ�¯hrÖšœ%xýè4�µ"m˜õ'?ù¡ËXp•ƒóàÚcô�‡é€z¾z'nri-³š}‚Â¨4�µ€È0¨{p¯RïÚµ€JŠ ßUµÀz½V,—^óý¡ÍX$2'.fSDîàåäEýã§ƒ¦ÅigÞdSƒ“ß`ZÁ¼ÿ»ûÿÿåÊx<SÎ�eŒ¨¹˜¦«ßf�.¨5ˆ@üø?‹®‡käêÿ»=PXÔ.(X²Ò¾àS®…]râL¨ÐÓÿ÷àÇB>ãU=È™FwãT0ÝÒ=Ê!((�Q-X;¾ÔÉ­u áA�ÑBÚ&¸n ûÝŽ§b*K¥Urä?ü_p ªú…Wq†YƒÝ}‚P1â·À �Ûà±81É\=Ô­2/@Äcßœ58…+n7ßN?#ø?²‡ç�#­<çü}ØSMÇ®µ/=�Årô7Û®µ5çQüÏ…+1ßà…ólN±ëPAÃ]¾ ÝN�y×OuË™¶M\6Ô!zÔo=×lAÃL�;<}çÓEßý°Çò8ãñ×Þ~KÏá5GýqÌmØ/Ž¬‡Ï<Þì6‰Ô—±.DÊ•üá´û#ë’�On(¨ÿ¿ò>¾‡ø#Þýâú¾YVV�³h¸I¶¹®  ÐtÔ A u“Cc€Â¹ƒ®ÁQ}8¹ &ÿs?‰0Í¥3‚
s4È|çz=3ù3ó¾¬êëúú»=ÊÏ¯òÔîVÀþ¤
ñ©#©Ã~ÇýUz@†
Ü’Û?†G
«?¨r�/rº–Hè¯W�uÞ×ù»šê†¦P£Æ¬>h)Ua8j]U©s–¸�b"Ò�"KýÿM˜Õ66íi-5ô"KýÿM˜Õ66íi-5öKóþ^óöüÿ—¼ý+ÏÚï?Ø8yjªš˜Ñóî>á9¯E$„ê¨ù¨ÕS¿:&oj°nQl«6Q�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�Ó0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÌØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸L¸±X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßõè©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&é¶.&|±û“‘:–Ø-“Š¾"¢›ÎÝkÝ×gÁM•"Tø>XHN^Ý¥£(ÎÞ?:½,~,�N6–Ã×3 D0¨É 3ºó¯³·‡³Œì,¬8Ã	´ííPÂYÂ›ÝÐ\ÐT]ˆMT=5PôÉU2Žª½�ï?þM·Ulsµ-ƒüteF}«ÿ�NþÈÎïŠñþ<éðgâóêïëLƒ:»díÎ$&í+�²³½Nˆ�Åÿò´ü|ã>›Â^lºõü%Ç¦Ïx4ÓÞ	tM˜�Â9Ñ+¡H ùyÃ�äQtš‚n3¸áOJ~°UD “ºÃWWß8$Âª¢£SMs4UTµo¨n«œáÎÒÅ^Ü¥ªamUë~Fú¥iU…*•µ¹Rfa%z‡J}c¥´„7æí1¸¹«+od£áïòÈ‘—œg§Ûƒý#�aŸ1ÜíðïF¦ÓY_OOÄÍ‚ø×©¼ûÛÒæ–Š<9RJÏJY*3\¢�hçCl‚-ÎË*	ƒ­­;Â¿\mC�†ÿØ¢5U0¤ï¬/¼l¢ÑIJ4Šmí‚˜4Þ6Zîž-�o%ê¸‡‚{_RÚáH˜ÃŽèü2ÖpgÌ÷dÑz•Hí¶�W+¬{µéóŠ½+—÷²7õáºÓn©êßL«€„Õ]V<ÕT”wb…žÙî¾ªÖi¡M©´
h»a0gf¡bjEVWV@+ÌÝ«üU#ß‡      �  ‹    !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
   û<?xml version="1.0"?><Features recycledIDs="7,1,21,0" nextValidID="22"><Feature recentID="20" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6466" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="5675-6466" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6467-6535" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="19" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3379-4173" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="18" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1508-1510" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1511-1513" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1514-2227" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="17" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="921-1495" color="#a6acb3" type="standard"/><Segment name="ATG" range="1496-1498" color="#a6acb3" type="standard"/><Segment range="1499-1507" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4919-5504" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2541-2969" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="235-614" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2983-3312" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2271-2495" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="615-818" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3163-3298" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4347-4468" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6536-6640" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4565-4571" color="#ffffff" type="standard"/><Segment range="4572-4589" color="#ffffff" type="standard"/><Segment name="-35" range="4590-4595" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4610-4631" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="T7 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="863-881" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for bacteriophage T7 RNA polymerase&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4517-4533" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4541-4557" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  e<Notes>
<UUID>059de63e-f495-4768-a94f-65d6c943e1cf</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="1:38:26">2023.6.15</Created>
<LastModified UTC="1:43:4">2023.6.15</LastModified>
<CreatedBy>Triple Threat</CreatedBy>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  6¥     ú  /]        /]¿þ`�îÒu¸îód¥=&ã¿ŽˆŠ,á$ŒÄÕjS�uC¡ñÖ�…ã¤
C*Œã¬Æ'Ñ™Ì¡Úhy)¥’[Zpi+dý™�+Ì§eéÂVÏƒ‡Ï×üý¡ËYaÉŠý’\õ�¯hrÖšœ%xýè4�µ"m˜õ'?ù¡ËXp•ƒóàÚcô�‡é€z¾z'nri-³š}‚Â¨4�µ€È0¨{p¯RïÚµ€JŠ ßUµÀz½V,—^óý¡ÍX$2'.fSDîàåäEýã§ƒ¦ÅigÞdSƒ“ß`yÕaÂeFØvÇ�QÆuOJ´#þ/OãÐú˜zþÓ=`�¯À.»Ø8„¿^ñ  FÁ\"	è„þ<0àUâèÞN'×Ï77Ñ¸ÕãbŽUR@ëµ VT8!A< PL8µÑ;OÒ†â½F´HŸ`·9Lû@#ÂÖäDüàKŽ x ¾ƒGÕOÇ€C�ô?NÙã³àQ�Ün>« ñN"û¦ þ“æú×ÈFÈC€]tÐü=áŽãƒLQúÞ4pþìÌ6	…}ýx×Œ`ý?‡Ÿ± à@mKˆ-�A A0ýýî>ø!¿Mõ7Ð÷¾Ó´B?Ñ»¿Ô@øÿ‹ôHþhõUvÓ£GÏhö„?·tîû�ïÍ>»kßÿC®�þ¾ú-ûãþ­¿ÒéûÀïíƒâ
ûáDÞÛª;á“¸úþô×¾Eá+øSàáßûÓ\ÿïƒö>ÏÔÿö�4¢€Ó=!§oKI­L>þ>}OÔ-B7û¯¿Ãü?Ûþ'­ïÜöûüw÷ÑCô|þ4Ó~÷ÝLÓî¾EÐ�Ç~úþ;ëDúã¾?÷Ô­ø¿pëÑÑ÷õQEï×}8¿ Tãþµ?H¼Tý­QKÐÿMÓþë÷âñÑ¢ø�¿ÓïÐR4;o|?î>>Ý¸â?ãÿEúîŒæ£~KûÐ>8ÿç´„/ý?Øtú4ô;Þî¿øñ‡S�Dí¼4¨C…¨“¨¿ÿ®#ö´ñÓWbïÓþ?ê9ü¯ýM[Q¡.°ˆxŽí}øëÚÑ=ßßPá÷·´ƒ®�-û¥'àw}D¸àw~=DOÐñ+ýøÆŒ±ud�P½šg· ƒýÂÏ¹¼í�Â`DPOoÄP¶çpDïÌ(ÿhÕ !¼ÐÝÎN{�‚0ßCßxô\â-¾Ûàø¯òO°G¹ô·Ç¼˜ÿ}<Œ>×|ŒèõQÿ]ø‚>úï¨(¯�6'­pãRc°MG~ÍJóìÐ[õDR;ÁD«Ð~|RÎÿ‰ÔÇƒþÐù´_B\AY1¡ãË€8PPpþ³ -Ãã`zâ?s÷P}6_¹Ö7È.7ø}AG[8ÈF¿a4ãb»ÿ‰Ô`õÜJ‚LAÑcT 4Á=½íóëÿ1Ç>?ãÔ¾<ôÃN=4ñQF´PE8MïQµ4þàÀÚrÁý‹¸P h¿MCáOïíBóE÷­;ëRtÃ\Â9ì#€×�ïéÓatÈžù÷¾y�Óôø~òÖ½ïRs»òê“ž`êöô×üºÿ»Jøà�€Ò4ƒJ¡SÑûÜî7]>ðùÂá*<N?OCŠýÑÏßÞû}ôÓã'ô?Ôn:ýCÿç½í"ôþÿê?Dï^9×FöÔÔOIÎÐá>#ôG85G~âñ»E�ô·ê tžÐCõ6/ýD\"8"». D¾=²þNÒ¾ N>úýët`ô€+ü! ÓCN¿{�1_ OøÔ¨Ó~Ãè8Óááò8 Ð­{áP’ø
õN _öAA¯O4ÓÓ�Ð>/¨.?àÓN* î´Aâÿ­>OÿM@L!AP0‚ÁAâH]×¯�Ä]°Ã òôýÃ½¾Û#ðÀN7=÷<éE?_8÷ýüÛ³‚ëŸMÔ_µôý}ÀàþàõSNp7ãðà>ÓAS¹ÀQLÔ€ Þ £„ÿME ,¿ßÃCx8�ÝÃ|‹ï˜ùÜP·ƒþtó�¹¬Ïû¿¿ÿþ\§ƒÅ<èPðˆÊ‹™Šj½öhòêƒX„Á_ƒøºèq6¾@.¯û³Õ�Bâ…‹!AM+î:èQÕ×.$Çú�0_ÿ~t#î0õSÜ‰”g~5C×ý#Ü¢�’ˆÕƒ»íLš×Pý'ý¢`†à°�Øêv"¤±
UW.CÿÅ÷ r
¯¨Uwe˜=×Ø!5N+|ý¾�Ã•ÃÝJÓ"ðÄ@Æ=ùÃS‡øR¶ã}ðÔãò?ƒ÷û!÷ø~pÈÒ:ÓÎÇÝ…4ÜzëRóØüPç/A3}ºëPqÃ^uÌñR±þ_6Äá@Ûµ5ÛàÔàI×�t÷\¹›`ñÔÑEÃmB­FóÝvÄ4ÈÓ³ÇÞ}4]ÿÛpÿ#Ž?}çá7ô¼þT×LÆÝ‚øàJÈ|óÀmîÃ`q8�I{ä@ü©_ÎO±â>¹(ôöâŠ�ûÿ#ëè�B=ïÞ/«å•ahÛ6‹„�‹kšà € M@GY468Œ ;˜:áÓ€;�o÷3ø“ÚS0Àˆ §3L‡Îw£Ó?“?;êÎ®¿¯«³Ü¬ðêÿ-Nål ïê@¯’:œ7ìÕW¡¤`­É =³ødpª³ú‡(÷+©d�îŠõx]í›°¹®¨jeª<jÃæ‚•V†¥ÕZ—1ikˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ãîšôRHAª��ê�U;ð¢fö«áµÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÐq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµÍ�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýÿ^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn›bâgË¹9 Ém‚Ù8«â!Z)¼íÖ½Ývq<ÙR%O€#å„„åíÚZ2Œíãó«ÒÀWâÈôãial=s0C
Œš;¯:û;x{8ÎÂÊÃŒ10›NÞÕ%œ)½Ñm eÍEØ„ÕCÓUA|•Pó(àÊ«ÙóÿáÄÛuVÇ;RÑ1_ÇAæTgÐÊ¿øïìŒîø¯ãÎŸ~/>®þ°È3«¶NÜâBnÒ°‰+;Ôà8ˆÜ_ÿ+OÇÎ3é¼%æË¡/_ÂQÜzl÷ƒM=à—A¤Ñ1	‰#�º‚—œ9ÞEI¨&ã;Žô§ëTJ	;¡¼5u}ó‚L*ª*54Ñ§3EUA»QFú†ê¹À.í \UíÊP ¶¦ÕPn·äoªV•XR©[[•&fW ¸t§Ö:[HC~nÓ‹š²¶öJ>ÿ,‰yÆp:}¸?Ò8ÖóýÎßôjm5•ôôðP<LÑH/�z›Ï½½.ih£ÀS‘%$¬ô¥’£5Ê(öŽt6È"Üì² ˜:ÚÓ¼+õÆÔ1)ØoýŠ#US
NúÂûÆÊ-” óH¦ÞØ)ƒMãe®éâØöòQŽ«ˆx!'µõ-®d‰Œ1ñ(î�Ã-g–|ÏvM©TŽÛhrºÀ1W»PnŸ8¡Ò±‰{#^­6êž­ôÊ¸MUÐPÕcÍU@Y@ÇpV(Yížëê­fšÚ›@¦‹¶vj&¤Ueud¼ÍÚ¿ÅR=ør      �  Ù  /\  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  'p<?xml version="1.0"?><Features recycledIDs="0" nextValidID="22"><Feature recentID="21" name="TET3(human)" directionality="1" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="974-6361" color="#ffcc00" type="standard"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="1" name="ZF binding site" type="protein_bind" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3737-3748" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;CCR5TC zinc-finger domain&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;target sequence for the CCR5TC zinc-finger domain from the CCR5-224 (+) zinc-finger nuclease (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/18587387&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/18587387&quot;&gt;Perez et al., 2008&lt;/a&gt;;&amp;nbsp;&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/23791193&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/23791193&quot;&gt;Gross et al., 2013&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="20" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="11920" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="11129-11920" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="11921-11989" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="19" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="8833-9627" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="18" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="6962-6964" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="6965-6967" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="6968-7681" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="17" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6375-6949" color="#a6acb3" type="standard"/><Segment name="ATG" range="6950-6952" color="#a6acb3" type="standard"/><Segment range="6953-6961" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="10373-10958" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="7995-8423" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="235-614" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="8437-8766" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="7725-7949" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="615-818" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="8617-8752" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="9801-9922" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="11990-12094" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="6361" maxFusedRunOn="6361" detectionMode="exactProteinMatch"><Segment range="908-973" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="6" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="10019-10025" color="#ffffff" type="standard"/><Segment range="10026-10043" color="#ffffff" type="standard"/><Segment name="-35" range="10044-10049" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="10064-10085" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="T7 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="863-881" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for bacteriophage T7 RNA polymerase&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="9971-9987" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="9995-10011" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  f<Notes>
<UUID>059de63e-f495-4768-a94f-65d6c943e1cf</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="1:38:26">2023.6.15</Created>
<LastModified UTC="1:40:46">2023.6.15</LastModified>
<CreatedBy>Triple Threat</CreatedBy>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  7³      ú  /]        /]¿þ`�îÒu¸îód¥=&ã¿ŽˆŠ,á$ŒÄÕjS�uC¡ñÖ�…ã¤
C*Œã¬Æ'Ñ™Ì¡Úhy)¥’[Zpi+dý™�+Ì§eéÂVÏƒ‡Ï×üý¡ËYaÉŠý’\õ�¯hrÖšœ%xýè4�µ"m˜õ'?ù¡ËXp•ƒóàÚcô�‡é€z¾z'nri-³š}‚Â¨4�µ€È0¨{p¯RïÚµ€JŠ ßUµÀz½V,—^óý¡ÍX$2'.fSDîàåäEýã§ƒ¦ÅigÞdSƒ“ß`yÕaÂeFØvÇ�QÆuOJ´#þ/OãÐú˜zþÓ=`�¯À.»Ø8„¿^ñ  FÁ\"	è„þ<0àUâèÞN'×Ï77Ñ¸ÕãbŽUR@ëµ VT8!A< PL8µÑ;OÒ†â½F´HŸ`·9Lû@#ÂÖäDüàKŽ x ¾ƒGÕOÇ€C�ô?NÙã³àQ�Ün>« ñN"û¦ þ“æú×ÈFÈC€]tÐü=áŽãƒLQúÞ4pþìÌ6	…}ýx×Œ`ý?‡Ÿ± à@mKˆ-�A A0ýýî>ø!¿Mõ7Ð÷¾Ó´B?Ñ»¿Ô@øÿ‹ôHþhõUvÓ£GÏhö„?·tîû�ïÍ>»kßÿC®�þ¾ú-ûãþ­¿ÒéûÀïíƒâ
ûáDÞÛª;á“¸úþô×¾Eá+øSàáßûÓ\ÿïƒö>ÏÔÿö�4¢€Ó=!§oKI­L>þ>}OÔ-B7û¯¿Ãü?Ûþ'­ïÜöûüw÷ÑCô|þ4Ó~÷ÝLÓî¾EÐ�Ç~úþ;ëDúã¾?÷Ô­ø¿pëÑÑ÷õQEï×}8¿ Tãþµ?H¼Tý­QKÐÿMÓþë÷âñÑ¢ø�¿ÓïÐR4;o|?î>>Ý¸â?ãÿEúîŒæ£~KûÐ>8ÿç´„/ý?Øtú4ô;Þî¿øñ‡S�Dí¼4¨C…¨“¨¿ÿ®#ö´ñÓWbïÓþ?ê9ü¯ýM[Q¡.°ˆxŽí}øëÚÑ=ßßPá÷·´ƒ®�-û¥'àw}D¸àw~=DOÐñ+ýøÆŒ±ud�P½šg· ƒýÂÏ¹¼í�Â`DPOoÄP¶çpDïÌ(ÿhÕ !¼ÐÝÎN{�‚0ßCßxô\â-¾Ûàø¯òO°G¹ô·Ç¼˜ÿ}<Œ>×|ŒèõQÿ]ø‚>úï¨(¯�6'­pãRc°MG~ÍJóìÐ[õDR;ÁD«Ð~|RÎÿ‰ÔÇƒþÐù´_B\AY1¡ãË€8PPpþ³ -Ãã`zâ?s÷P}6_¹Ö7È.7ø}AG[8ÈF¿a4ãb»ÿ‰Ô`õÜJ‚LAÑcT 4Á=½íóëÿ1Ç>?ãÔ¾<ôÃN=4ñQF´PE8MïQµ4þàÀÚrÁý‹¸P h¿MCáOïíBóE÷­;ëRtÃ\Â9ì#€×�ïéÓatÈžù÷¾y�Óôø~òÖ½ïRs»òê“ž`êöô×üºÿ»Jøà�€Ò4ƒJ¡SÑûÜî7]>ðùÂá*<N?OCŠýÑÏßÞû}ôÓã'ô?Ôn:ýCÿç½í"ôþÿê?Dï^9×FöÔÔOIÎÐá>#ôG85G~âñ»E�ô·ê tžÐCõ6/ýD\"8"». D¾=²þNÒ¾ N>úýët`ô€+ü! ÓCN¿{�1_ OøÔ¨Ó~Ãè8Óááò8 Ð­{áP’ø
õN _öAA¯O4ÓÓ�Ð>/¨.?àÓN* î´Aâÿ­>OÿM@L!AP0‚ÁAâH]×¯�Ä]°Ã òôýÃ½¾Û#ðÀN7=÷<éE?_8÷ýüÛ³‚ëŸMÔ_µôý}ÀàþàõSNp7ãðà>ÓAS¹ÀQLÔ€ Þ £„ÿME ,¿ßÃCx8�ÝÃ|‹ï˜ùÜP·ƒþtó�¹¬Ïû¿¿ÿþ\§ƒÅ<èPðˆÊ‹™Šj½öhòêƒX„Á_ƒøºèq6¾@.¯û³Õ�Bâ…‹!AM+î:èQÕ×.$Çú�0_ÿ~t#î0õSÜ‰”g~5C×ý#Ü¢�’ˆÕƒ»íLš×Pý'ý¢`†à°�Øêv"¤±
UW.CÿÅ÷ r
¯¨Uwe˜=×Ø!5N+|ý¾�Ã•ÃÝJÓ"ðÄ@Æ=ùÃS‡øR¶ã}ðÔãò?ƒ÷û!÷ø~pÈÒ:ÓÎÇÝ…4ÜzëRóØüPç/A3}ºëPqÃ^uÌñR±þ_6Äá@Ûµ5ÛàÔàI×�t÷\¹›`ñÔÑEÃmB­FóÝvÄ4ÈÓ³ÇÞ}4]ÿÛpÿ#Ž?}çá7ô¼þT×LÆÝ‚øàJÈ|óÀmîÃ`q8�I{ä@ü©_ÎO±â>¹(ôöâŠ�ûÿ#ëè�B=ïÞ/«å•ahÛ6‹„�‹kšà € M@GY468Œ ;˜:áÓ€;�o÷3ø“ÚS0Àˆ §3L‡Îw£Ó?“?;êÎ®¿¯«³Ü¬ðêÿ-Nål ïê@¯’:œ7ìÕW¡¤`­É =³ødpª³ú‡(÷+©d�îŠõx]í›°¹®¨jeª<jÃæ‚•V†¥ÕZ—1ikˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ãîšôRHAª��ê�U;ð¢fö«áµÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÐq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµÍ�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýÿ^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn›bâgË¹9 Ém‚Ù8«â!Z)¼íÖ½Ývq<ÙR%O€#å„„åíÚZ2Œíãó«ÒÀWâÈôãial=s0C
Œš;¯:û;x{8ÎÂÊÃŒ10›NÞÕ%œ)½Ñm eÍEØ„ÕCÓUA|•Pó(àÊ«ÙóÿáÄÛuVÇ;RÑ1_ÇAæTgÐÊ¿øïìŒîø¯ãÎŸ~/>®þ°È3«¶NÜâBnÒ°‰+;Ôà8ˆÜ_ÿ+OÇÎ3é¼%æË¡/_ÂQÜzl÷ƒM=à—A¤Ñ1	‰#�º‚—œ9ÞEI¨&ã;Žô§ëTJ	;¡¼5u}ó‚L*ª*54Ñ§3EUA»QFú†ê¹À.í \UíÊP ¶¦ÕPn·äoªV•XR©[[•&fW ¸t§Ö:[HC~nÓ‹š²¶öJ>ÿ,‰yÆp:}¸?Ò8ÖóýÎßôjm5•ôôðP<LÑH/�z›Ï½½.ih£ÀS‘%$¬ô¥’£5Ê(öŽt6È"Üì² ˜:ÚÓ¼+õÆÔ1)ØoýŠ#US
NúÂûÆÊ-” óH¦ÞØ)ƒMãe®éâØöòQŽ«ˆx!'µõ-®d‰Œ1ñ(î�Ã-g–|ÏvM©TŽÛhrºÀ1W»PnŸ8¡Ò±‰{#^­6êž­ôÊ¸MUÐPÕcÍU@Y@ÇpV(Yížëê­fšÚ›@¦‹¶vj&¤Ueud¼ÍÚ¿ÅR=ør      �  Ù  /\  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  (~<?xml version="1.0"?><Features nextValidID="21"><Feature recentID="20" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="11920" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="11129-11920" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="11921-11989" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="19" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="8833-9627" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="18" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="6962-6964" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="6965-6967" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="6968-7681" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="17" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6375-6949" color="#a6acb3" type="standard"/><Segment name="ATG" range="6950-6952" color="#a6acb3" type="standard"/><Segment range="6953-6961" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="10373-10958" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="7995-8423" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="235-614" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="8437-8766" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="7725-7949" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="615-818" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="8617-8752" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="9801-9922" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="11990-12094" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" cleavageArrows="973" consecutiveTranslationNumbering="1" maxRunOn="6361" maxFusedRunOn="6361" detectionMode="exactProteinMatch"><Segment range="908-973" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="6" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="10019-10025" color="#ffffff" type="standard"/><Segment range="10026-10043" color="#ffffff" type="standard"/><Segment name="-35" range="10044-10049" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="10064-10085" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="T7 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="863-881" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for bacteriophage T7 RNA polymerase&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="9971-9987" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="9995-10011" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="ZF binding site" type="protein_bind" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3737-3748" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;CCR5TC zinc-finger domain&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;target sequence for the CCR5TC zinc-finger domain from the CCR5-224 (+) zinc-finger nuclease (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/18587387&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/18587387&quot;&gt;Perez et al., 2008&lt;/a&gt;;&amp;nbsp;&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/23791193&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/23791193&quot;&gt;Gross et al., 2013&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="Kozak sequence" type="regulatory" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="899-908" color="#a6acb3" type="standard"/><Q name="regulatory_class"><V predef="other"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;vertebrate consensus sequence for strong initiation of translation (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot;&gt;Kozak, 1987&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  f<Notes>
<UUID>059de63e-f495-4768-a94f-65d6c943e1cf</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="1:38:26">2023.6.15</Created>
<LastModified UTC="1:39:24">2023.6.15</LastModified>
<CreatedBy>Triple Threat</CreatedBy>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  4ý7zXZ  æÖ´F !   t/å£áÊ¹ñ] Ë‡ØÎf‘ƒÊý{3Ôé·Ú(1v%f M*	mj÷)p80çÌ*iÚ	´NY]Qó“�úF7î&ƒÕ!Ò÷ÀnÉ;_x�Ðß�’Îe6¿õâRO¯Ø/ÖéßÑLÝnæƒ‡÷es�ÝA<Ë…u¡	³~ù©¥e@@Ýd³¬¶	‡·¹Ž_"Õ“¢ä©×÷L?òD´m~öZ[ÏH<UU1T˜qe¿Qúe²îØäQ�b�®Hƒé<ƒXíŸD5K•øzc¼&•²Ô{�@íý ‡“@3%'r•bBÅˆû8­ñ@ô½Ûâœ"úL‰AÃ…É�ü‹ZL{`ùÊ¹Qãá�I[=AÑ„˜�‹Ð~J$‚¾4Ì‘~Ôž«Ì±™�Áå°¤t^ç»íùCÖÃQ²ÊŠFð¦«¶„¤Ï{ºíOèÕI·ùÜ†·­&P$gPËM-„wdŸ0áR‘€×b¥ÞaÑ~;±©‰œX�dt¿½�ƒ3Ðp*¨UBºÿÑÒ[~q²|:9ÒVûLýŽåÈV†·HÊ*ã(òr&¹©„ìº36Í®“ÖLÈ¸#Mû¦§;¬ŸªŽø#±!¨uû�˜ïC¿ÊWÊû«Y˜IÃ�/ŒÏ9ôfåÑå6%Hh¡ÊdÞQ‰ø‹Ow€+MU#ž¤«Í[CØ˜Åþ¹àÓ£î¹=ðÒ£uú^wÿðÎ¦wÉ�Éó’çU‡ÎjÙ`Â}t(þÚ¦Oë(Õ€†™;¿,+pRü[h„ÔÐÖÿÕGCÛ…0V˜/"=É!î$òÍh¼Æz¡Ç«å¨Sü„ä]Páìz(ÅÊH¡r—Ä Ž¤q�¡Óô)Þ$Q·|ß"¾ãÃ‚îáüqx˜M4ÓàNdú ùeÄÿm·íµ·f.äÃ„U)Å¸š.wTÉ­“u‚ºµPDÉ“©Âí¿IØ!$LW,ëòiÝ¸“l_ä�æFÌJGŽà^Õ1±Î0š/jTûPù¶8{|e^±	ÏËìKÛ¡aõ”�DÌeû`ôI´ç�Ûq€+A\Ô·ÙVEÔª€SØ‡å+Yßv‚”ãÚL³GîÍJ�Æô‡âÖZpQG[í‰ûdÝ
ÚrG™8QŠû*§¨2­;±îñ
Ý8 "73‚Í°¿²ÙR	 Ü]4@ihÎ
`_;fÜ®´¥ò¹ß…Íf	P¯oºöB\a‘9‡ûpˆ´¸«î"‰–ê{9êò[b3¼’~_¹çÿ;Wn9½#³!Y{#êƒâÀ¦‰Ó~–hwŠCŠ¿°Àmð?û‚,^NzžòþþŽ‚ »…Aûå4xºäÎS¦mS#®ìæÜÿÎwßxÇVg�ý^%"[P,B›˜à´‡¨‚‹ äC¶ˆ_r|[ÕkðM5`ÝŠUÈ§]Â–n½þÃÇ2=o{wuÑ‹½ï9ˆ&Ù”#ßƒTé×}úÈ<'B�¦Q›íÏµàNç1X%þ½2‡?%eÝŸT—ü¾ü…B…óÀª?)2ûbäR‹îI¸”ÝhQ¦ù«S�¾\JÍ1çVû,ð¨>ˆNtÀŒ¸á+¿—ø–ÂÞå)È—…äYã¹öFNÂ›~ó¨.÷Uñ@<)W›&�¾¶�Ô†~*¶AÝM›#³€»þyò@¿�Û7q@ü�+–	ÞLM®#uôÍN5k0S:‹WÇo Bî3-Å3ÐšF(¬r`«uždúê0¾¿¥1á¨:¢k8‡3›3Ñ@þwsXöûuVƒÀzaãlöA3ÝÿQÛ‡x²­—Ï%Ý^÷Kâ·l°ÏÂz7B ’ šq¤â7AßHd—ù{äþG]£ˆ¯ñEaû¨%«¯e˜»¤OÇ™DJÙQ„`Â‹ X-‰£ T�,£Â„ÅÂí5ðãïïØMÞ•¦ Zð^Ðð	Yx-¼Í<ô �7Â/-CùþTûÃöíü9f“ræÕ}™«/+ìN¢©=Dß—òÅ•ÿFIÿ×}•ÅÏ«7mÙ‹©"Âºz!Ÿôr7ŒT‡‹Â†Þ ÏðâdkmßN±æ¾ÔUHI¿õÝô ¾ySGŒ˜¯4Ä2Qý„mU/ˆN¦y¼r�D)ˆ…8Ã0µÂÀò™±aM^Up›rö?ûZ	‘Šýp÷Â†ðàÇ¨
^Z0l"¸¦ÄmH§ÉRë�\óhJƒCª?#Õñ„jÃ™WDÊžE3Á_Á–5zau];®1<o¦g³H¡ävùB~"ì)9áhÁš¤·“Í¡ž¹ÀÖƒÐßt17à
ÔŠÏ\anç	¸Ë’”=î¶ä|ÄðeÌ#¶„¨¬ûèBÝ+ßcÎæÔc¨ºìD 0r&~ìÔ\¸i�·¿©I’~Õ€dòKžp•Ù¶š„C“@>Û‘xY…‘¿oºôÜ5—PR±èß{e®K©gÄdY€	>t™Žb²šêâV[W¯ôN[wÀg,{Ík¡±À6`yL!®;üsb ƒQ–Ç¶‡£B¸¿¡."jµäX»÷I÷)´U�Ú–ˆäœÍlú,“=…¤

ÐzÓƒb«ªœ �ý�½²øEøJëp÷³ÝZî>êÚs†ñ_îÕ8á»G>³O7+1²ª¸ Jé~ähòÍÑ¦J™uT?Må¨u$xhãÌõEdè î+�,ÉK:±y�jX:îÙý|V,Ÿßoí%Ó¬°É=ÑiüccÝ²¤Y›³þ$¨LBU<!BÒ8¤g /}]j¡×|ˆØ÷òÛ÷leHam˜óÎNˆ»Ž,”2wÄ>É}Þ•õiMÚy)äw˜©OˆD9.ò(|¶\öëx�éäüÉžvP‘AôåCýZ2°ä¾ØL/3.#l}la¤‹;‹‘Pt1«ª¸¾˜lžo �’‰³Azæ‹ÜË6kvÒˆça·®håº^I‰´gkVWlr«×ZàtÒ½ð6þº…)“ÚÊ¦—3R¬gat7âñ¸sM‹¯7¤W&mUÓ�û^²ú°€Ú°ºÏ:Åýk±0šc$Z‹@k©ØÕ—h‘”,X$I�ÆJÊ  þˆü ÉíDm^šÓ¿*íc`!²õÁöquö¶EHÏ¿–X"˜r¤ú×•÷Öy/<á0WM¤=q|Ç5ó»I··Lð®E5)2÷JÙ�B8Ë©h‚T�GQrw	¢ñ†êžçu¥âø/r›pà:îµ¯F[‡,Â×•ù—{ß@DéÃ:UÒsTpæBaY²\›#ÿ�Lž¶|ÙŸwùpLv­Ÿ‚Áo¯§$\Ù³uÚW�€V«[V-¶“vxùú¢à!ÆfEÚîŽONÍRÄ‰Ì3À­¥Ä	U‘»ègî^!:ZÌ„¼4ènàB¦Ñ"õš'½>]IÓ@þ¼1D×ÕÛ;ÜeÌ("O>	ÈÓÊ4ØKÕfsŽ‹>D×�°¼Æd9yJf}±|#OIã~q¢Ï÷Gë‰×xÐ7{±yµ�YÈnSù<–ß˜æÂãO¨f‹ºÏyñ‚p  lWµI+ŽŒ0dZÞ%—H%á¤!×ž!Beß�¹„‘¢'…5Ž^×f!ŸÍ‹­Ñåí•igµ4ŸÛù©	#ß¦J(¨ô›É�$Ja³Tv•j'w0Û¹ÚªN\–4pcÍ“üùÌ‡×¥rN *Ï7á×Þ,N'É:[›áå¿põo '­õ ZÇ†ÞÇ¥V!€z•/�¿)TÔ^ež ì%™`€„Àj¼‡»yÅ.a5$ÜFà·ÍòŒ'¢C<¶y)@Œ§CuÃ‡©±{e–ÓÁä`„W—ôRè0f £.'†
ÄH¯µH1m·Deû•äm>Ÿ·ñ46±EwSSŠ`8t%@ÈK˜XfóÖ’•½°€1;@R•"šÙLA_øbÂ^*§©}:qJ¶Aîæ—ºþ£³†™úÄìçàõ€Žä?m-TšY�8ønÕ‹‚ç·+±û á)j>�^ößõ�À¤[Å<¤vó§…â‚6�ÄD ü§ÿ,Îk6
 µ¤ýsqôúº‚h)µ—²ó/�”µì[ìK`Ñ²@ØâÃ,ÀÊ9ò¾ü„Æmn?›ÿuùÃË‹oÛá&Þ$æ×ðx4gž²‚†2PÌ_ƒüÉÈ$Àg!nŽãxLµ +*™üd¾HÒŠÆ~ïÞôŽrÌz£ c½¹Ô÷ËM"ýš+êLI2î/ü(òVC´—õ5'€¿‚%†@FÐQÄN#²�ÐýÖ*!·t+Ðœ™‹ÇLçø���î‰ÂAeÙ�×š/îû{“ª@òÌÔÎÚxø4ÍZMvgþ¤¼	ÊúWe†ÍåÝØGÕLÙ�ð6‡¿%ë<©-µ„ÐY*Aæ¾\š²A¤±¿€Œ6g�I†žz£)*‚¥k7F°4aŒ¨‰¨Ð"]G>¡~5|ÆÉi€YäMº½Ó»{‰)77m%Žzë‚›©UÛ’½�­¥ÍJõ.
hjvå+·ˆÂ' ¹WD•¼of“dŠ½Œ;íµ´˜ý®›b}CµÇßlŒ×Á×°ÄkÁgÛT(ôTŠÙjè�o–žyÏš3g�À¼Ð¥�-¦€qü"¾òÙ
¬cGÿ2\cˆ­?÷¾—3±”¨ÈQËù'ªq¹ñœP�÷¼ÞLH2³a÷2êlöÒx¥×Õœ¸,ó®�íñâB|F &U{j¤C\ <úŒl–Å+ÛZ�¢Â&ˆÙÆöÚm�j,Æ÷ÚÇœB¯B�Œ¨W£ÛÎ|¦·=îÊ>>_$›L z`FgŠ5‚çsTVèÂà/9íI€hc.ìÀ>xÀåZ'³m�|]AÍÁ<^ :Êu3]ñ³<(P£3ÊJŸÆª�*¾½·~é»¯¦`DW² +™—xå£ÓY´¤é˜´l“…öA…àƒ£è?}‹Ì,¡µ“0Ïæ©þ”¢¼€z|cÔçh¢]]5³–KPšâ&X%Ö˜\.L�ýTºve�¦ÃÜ¶J­ÀV` ÎA,U´§Ü<í¢–}ôULæ‰9þö	X†ï‡"¶§IR%'T¡ìüvVf,^ØÈ&©Ò-þ.8]\„´íÅÒro�ÇìuPÜºÊžUÁï­†‡0!£ðè¸X‡¥ ’à·ˆrúxTiÀ n�ìÖ…fÝ�X¸1Zƒ_‡Cs~à[*ÙâÆn+h‹XôSÛ¤œ¡©)�Ón9³„^tAÎsTNÏq7O‰‰BË§¼ZC™!ïý™AŽ,UÕ�‚øcr¶Ø³Ðn*Ù''ãg_v×ú'ZñB#qýgì¨uEØÃM‚ÜÖ˜" b›$gk35‰b^°‹•õWYâiŽ“¾ˆ¾ú3E£ÄÒK•&Þ¡¤³„/U¹£K�L×ŠX¹å6eù—S¡1[2ëUÅ£¥‹‡3AkÒ!°ÝB,áò†Á®ìmEV÷ÙÇVŠ £zé!æ˜¦•w^M-û^((¡UúÄ»kcÁF¢�ù³M+.}št ¼ÙDàBû0 ‰8â�—5Ž‰ªï<#ù�z Dóým1|Éiå,¦ÈÔãÏ”>˜Uteÿ¢¸põL’¿ê>a*„
)Ì>„:Æùï¥~€TR%E³QiÖ(XBjoç!§$ó+[GI/Ì¹!æÀ©ü¹ô-¤”WeúÞzsªaò äÅH–Ù(      x.l¡3- �"º• �í,±Ägû    YZ  >      >
®ZTR

SMP4      9ñ`  xÁËÏ¶kšôã8¯Í½{ž÷ý¾µVÕZUM!ÐUÕ¤©.@�©†Ö„@5Ê€t÷ÄŽÄÍH´•)$$¨'’˜˜\'ÎŒ‰€1QçÎŒ‰a"ˆÐt×Zë{7ÏóÜ÷}mÎÃß�ûÊÏ!YÈ6§œÖi™¶íóõééËíùù;Ï¾Z¿øü«?ñƒïÿàø ¿_>G(ÿ ÀV6ü;%ã•„PüÓ’ðÊú«åoâÿÆ 'â?þ¿þñ?ÿúõ_üÁÿ÷Ï¾þ~ñ‹¯_¿½½Þß>=^^Ï£Ö1†;ÿìÿ'ðO†Á\„¨H QÉ�@¤@@è%CàHÁIAA	À”œ%B‚9à @ÈFr‚ G€œŠˆ„ ’!‚tÒIt€@¤“*	ttt t@¤Ê3è%�^8)�° 4ärI¤3H¤ƒNªÌ ƒrÂ	‡ˆ�¦nÞMzè DŠN€0Ò�‰fÉ© AaÐ›ÉM4°ü6$oÙ¦Ä^àÁUþ*$y‹ˆ)œ©e! ¨ü[|ŒNä”âðN‹´dÆòg *tvbNÔÏ¡,Æ¡`Kˆµ™'D‚£‡‘8Êh$›S¢÷Îˆ„`Aå
ÁÇ�‚%“*Ú$ÅÁ Hƒ'§‡ßÙÌC,"ÔÌcÚ†ÞÆñ)Ì«×Ñ[�@DŒeƒÈ¡ÚÇ¼­Ç½Õ%ÄHDh¦8¯‡·[ÓÄ4 Þ-?ÝÎÛ™·|�Ñ�ý±bf”Yù.DY¹%âðÃbŒF±üë Jå¼Ý÷�#åÙH¨üž-L—'àñ²;Ó”Äò:N·KÇëû9ÏóòlxÛ�£NqÚ‚Žz;úW¤Î²A �–?†ô~¯ÀÅ6oá|ô#ÅLágË6«½Ýïgº¤`C*W@?.ß‰ööúmçeš!ƒÊW8Ü¹Nkë­�k¶UI^.�Œ½ž¾~~ÅþéÛ—¾>-¤Cåãœ¶ËtÖû½ç´FEzùc�ÂPëa}þ€örëXfË‚ ?Ô×ë‡{y}´yÎa *ß…õáSºžØ÷Þ,Lqõ:Ž¶cŽÁËß€†÷n×Ï¯gûôéÞŸóºË òëÀ®êùCšŽúíîOëâ T¾„ è!LŸ/<ÞowKy^2ÔÎÖbT ‹"äÏ¾›ñO¿þC„/¯zÐ],õTÞ>€Ÿ>Ý÷<¯  hÞq½\ýíöéÀ¶Ñeð½‡øÝ9·÷·Ý¦)H*¿Ð¹[þ�ãýñúr`ž×9ŒÇÛëŽ<§¤òS@ÓX¦ÏRy«ëºZbÊ¯B%âôš>ß¼Ý¿þæX®+fÛÏýP˜#bgù!zï5Ì+y>^Åi‰0zù-¨D´ÑÂg—öòúMÇ¼^·)ÖãÓ1.—¨ü{Àá§ìòAýþ:Þ–�ŽÇíÍ>¬›q Ð8lOÙÛã~OØæÕÂéûm›‘Ë?‚dìgÕúÅ“n·oîiú,q@G8mºÎù~>Ž±ÄÙ%–_† zÕXÖë´÷oow<å©çf,ÿºŸÝóõûý¸#¦¤$/zoœÒó<Îû>Öi‘8ü<óöïoßÜîa½q *ÿDÐÑR^gh?ûð¼Î1Þê{M1g“ÑË! ã¼|Üøz|»c^'Ù�ÊïB FØ>f´ÛÛ£>‡ùšÃù¶¿wÄpÅ…÷ÇÆ'ËÃèåÿ€@×	Ùóîçí]ñ)&EzY!€Ýâó†úéë×—ø´��ô²B»÷x™©÷½6¦	zù	Ü¤ÞîaùÎSŸþèä9Tþ_ˆ@ï‰ó„æ÷þXmZ´ó¸7‘qË÷Ç»lÞ £—°6ø‡§MçãÛ½nÓôqI÷úþ*Ë›ôò%D¯§9ôþhîQË’[ßÏ—¸õ$/ÿ>zëJùãÒî¯7žaý`«ßÇŽrp£—ŸCàPCÚ–ˆýý½)Ï×Ëï�¾ÄÝèeƒ@W­-=ÅëcÿºËv]§°÷W1mÙY.¡3"^ç([F —ß‡¢º§ëeé/·7·9<_ÖÑnï;ò5æN–ß�@o])œÃþxAŸ¶§0é~Þ�0Mnrp¥�Ÿ¹Þ¾}yÕ¶e„ºwGXcôZÏ6lºnÖúë[RžÓæ¸µ½"fKÎ¡q:§iñqžª!„B;Þ÷3Æ9‚ôò×!²¡¥t•?öÇcNkB”—¯ ‚ÒÑÓzÙúËû¶L“Dzùmˆ}XZ¶jõ¨=)#:½|‘�GŽóâ¶�¡hÉ¼ü"Ø{ÅåšìØ_{Ã4].¯Ç›hsB —ŸAdÇ�%=ç:n÷>æ45^~"Ç¸{Z>Ìu­ãcÈI€Fžæ(Õ:‚%Æò?B¤:wËó½¿Þ‡¯yYuöýá=ÅyU÷þØ½a]?dŒóý~ÆxQ½|	‘£³%å£"3¢èå×!rôÆi^–QÏGõ)fDà½�¸Lêu?÷Â¼,¬÷½Öeš-À ö°|9´¿}:=^®AN@½™ÒÇ`ïíýPž™J„×T×)š�£{Xéå_†Ð‚BZF«cžWX÷[ëÈÓt•¿ùãs4’^~"»Ø–ºŸ{1ÌÊ^"Z<ÖÜÆ¸·³Oó²Íu<ö[XíÒ³ÓË!Ê{Èóem4L9BùÍâe´qœçˆ\èå¯CDÅækâq<—œGìå§1võ¼EkííØSÈ9¸ÜÖ¯Ë%õz{pä%°ü›Ñz°y‹:êí~_Â|�'{k{Û£­WF´ã>†¥ x¯ë¶ûûMJSš\V¾u4³9‡ÑÇ>‚ÏSNP?Ï®.@óÛ¾+a
åïÃ»Æ§ÖÚ:RÚ&³ÚjÁb@(?†P½ò2}:oÇ#ä9åûpo²�¦ØíÑ³iš{§ŸŽ”˜ ÷æ)¤)ºŽö0ÍÓ%�»îÍ‘¸"°üÕ›Móîïç¡°N+\õ8OLÓ0+Opí¨i»ZÚo÷wØ´ Šå§p?Gˆ—	ÇC=-)* ÑŽÄ§ç‹ãñÍ½�´^—Åëþ¸5K6G:Ë÷àã\—ŒºïûÌ)Â¬üîgË–Ùz}4Ï)E˜•_�û‘<]Ãüð³�žcFË�!4¢Æü¼Lõ|9ä<%˜Qå‡p�a^÷v;ZÌ!–ÿ	ò&Äi1½UKÈz—‡˜†vx�à„Äò›pT÷§%œªG¾…h2Et8§ÃMP£•ŸÃ©ˆ†N[gãxŒ¦)e*H,
›�6O[£¿>±LÆØÉò' ¸ûi#M3¡†)¦Ü4k)Fª;SNsZ¯²æ�…Z{Å–�…æí¤ÏyÔðJNLH`ù5WðùºDßm\¶”¢á´ò{|@Ê×Èz¾¾ëf¡ãµ![Hˆ–	’F'Rš<ý�“ÑÀòpÈ‡âe
R½�Š0Y@ Zùï!oòãô½5*­!£�ý„YÊ‹Bß[wæ5…aÇqÀç´Ný¨dDDLNŒfÃ–`ðól9ØD°¬ en3»û9#sF@%AèÍái[Rx÷G;1…€iòîÁÖ�Roít­i³ÔÑÐ•ÌR  ïÝc¸LÒù¨w ÇHD£—Ÿ@cœ@œ2âÙ½¦¨„ì `H‘>úé˜â6LãèîÃÔã(„a]AaŽ}o­EECå§FèbKë”ó;çP@ˆf`™ AÃ‡Ãæ`±âîn–s&Çî‚gFÄP~	B‡Ë´$×qT&C¢›ÓJ‚u#åé) íw›£Å¤ SùËF4Ý{@ÈÃO4s˜@•ÿhx3S°ÐÃB°ìËïA¼7ë¶ns¬ç·¨Êkˆ†@€ôò+à>Ú —Í«×ó��9‘A"ËŸ†;£Où*=Úí´9§)7’åÒˆ ºå¸Î~B9O9:ÐÍRÎ&k‚lD+?‚àðá5cÊÑXÛé€…ˆP"zpÆ‚P«3Ç¸µÁzŽÁ‰!§,?€¡%6›ay"ÍÀò÷!\jlqNKµ·�	É#A´ò#È¢­)uìÉ$¹‚[ùä¢Ã»<¦Åæw>Î&ÑP ÓÊwáêadÆst&šÇ–eË
�Kp¯Pš6¥ÞÞÏ9dDë�*_@ w ì±Ø7¯™c`DEbù%ˆ€D—”Â’Îq4d&�].ÐL,
’¼£[Ì™ñw·˜æ@µÑ‚Á£,w€N+ŸC�äC#…	2Æ@¸ÑÊápÀ‡¹#’w´ 4|ÀÒDóŽZŠ‰’\ Y~NÂ1à#0eŽÞ¤˜æœÝNÔS è€@•ÿrõ†hàè#f$6ºX~‚Ã‡‹IÞœ“-Ê£2¶HK.w)bV8GôÀ`Þ‚hË¿A•ÜÀÚäb TG‚. š@'8a Q�u¶˜iôæJÆ`„ D@Pù$ # ŒhA£[›•;�Uþ"$Ah¸ƒ	Ùè dùUˆ€à€k@–VOÞud10ëqP´ò] ‡k@L)ù¨£eÑ£e’…¬`5ÊRÁGc�d‘±Ë›š‰ pz²¨,S…+Ffs¨t#i„à’LR5WéÝ\è4ÑBêÁI€àáÓÿƒG·œ0áæ%B¤:‚Ó EÐ@7áàˆ$ˆ �,è8Èm$7� ••èNÂP Ñ`FÈåCŽ)Ð!Q¢IIÝzÍÌ88¼›†9$¤2r#Z@tHê$`` qé>¼#’sP¢“*	"Ð	–)Pp‡»–»uënÃEPT¤,Ëƒ��p�%‚r–¿IC@ÈJòÍ€ °ü‚†;Cdê�Ã–?¹º9sL0ïæ>[¦òw a Ç�³ÇûÊ /‚Ë{bbö�=¶HZPù1DY7Å�:<4@à�{˜6é<ûc±0Œ€0†õmË8�Û1³1/?€¤–ƒ•�
Ë—áãóåD?|cƒå· BÃÅ¸&ëã¬Ž”×	¼ï{3›—Kvïï»0gCàª#ä|·þ~Èæ) ÉË3Døhˆó|Þ¢[òàå+ˆÀPËZ—xÔý\|I„Êƒïôà�0&cùDÀûôO>ó_År¿ß<l!Ø�Ê�®6´\žÂþx¿×ë”# •+DP><\VÇqž
K@ì„zuá’¦öxÜRœbR„ª-,W�ã­õ-fs£—ÿ]§�é)ð¾¿bÀü!«>nµ3äü¼¢?öÑ§%%T¾‚H÷}™ƒ÷½+æaåé^“ç”„ó@˜H/ß‡µ ´Ç©ÊƒH‡@ï½Ûôlu?î}Žsp£—’±µfÛu­çûÛžÒ’j’Tþ]ˆ £+¯)õ£ö‘c„ÑË3D¨ÆÉÌOª³æåyÝÏ·O7K+ÉÍ‰æÖ¹éè³)åå¯A £¶qÙ>ö—ûãc¼�.*»L¶ü‡û§×GºL±ŒhåÏA F¦Oý¸½
kžÜ†T~ýÔó5�ãýý½GNëÇy¼}ºéãÍ!ˆPm\ŸóÀÛqË+Æåé)<Þ?½~�p]>^žï_ý©ÏiÚ¦íx;^[ŽËdàˆTû?ß€ýÛo~.—¼;7õZãôñÚö÷O/û’â‡Ï�÷oÎéÃ¶âñòõŽécNƒï‡_?ÿly¹}ý©f»^§éŸÞnû¯×k|{ùúÓy¦ôñÙðúöòMÆ2?_¦ðøúí°0oŸÛß¾þæD^Ÿ·Õ�·O7maz~J¯�·Ooç¼­OÏó§ó�Æ�yþøìýý¥#?“Aå»è:c¿¬ìg�çdiˆå—!€]ñã†ñ8n˜§y¤!•ïC¤{Mž2Ùzí®¶=xœß~{ÇÓe"9Œå—!Ð{Ó|1Ô½WÏ´Ï®¬û§GŸ®‹ÓE%Ç°¼�c<ö:ùD�åïAdG‹1'Ž³vY�>äu??õ}^/FØˆV~ttÄ%†vŽŽ%Yè,	ØÕ0ˆé¸ß­1‡aôò!ÛÙùüô¬ûÛËÛÓr¹†ãå[Gž·Ø£‰h­Ååé²·Û›Ï˜Òõ)ô··O�e¹G�—ŸAGÜCšç³Ö{õÐ¦ùãÞß¿¹µïä¥D¨\  M°Ëu~´Ûëç9ôò— rtô4göñè†¨(/¿‘>ªÅ)çá{�ùù9œ¿8¾>�·üav?¾®=æaôòëè5mK÷Ç£w2Ønçã�Ôã%ew¨|"‡7å´@¼�6:×�[{y­¯ñyÝæ úv»OS‡T¾„@W=]>CÿöÓžÖ)ô$/@{ëÓÇk|Ü>½…—æPùeô6jœ/Žû}¶iŽ,ßƒHï.›“±Ý+˜¦àV¾‚
·�·Ëò8_0æérÇùò ç…zù9DPÞ•¯akûý½.[H0zùØµ+_/ñøôÍË�y~zŠóí¸Ý^.ÛíþöÍ;â<?]c}{q[–ˆa€€^Çxúø¡�÷_Ü<|ºË€Þ[\¾³ŽûË§OáÃ‡Y,	ò
Ä%×Þï`ÞžC½½ÞaÊ“[gù[á§3Móyž�,I/¿h¨yzÎ½>nÓƒ—ÿ"½y½í÷€5eº•ÿ"ÆÉ1åhµrJôòCtí¨ÓóÜßÆÍB^×9ŒýíèqJDøá
ÏO÷·Š§-Mzùˆô†6Ï[çØ�3X6zÙ ‚B¼Úbß<^|Zç:Ë_ƒHgKÓ%ô±ŸuŠ³‚^¾‘®ÚÇtYFÝoGKÙ²½léãlS¸¦p;ŽÝ8'z¹B¤�³k™·ê{ÛÍrB —ŸBäè>R¾˜ê¹KV–—DpXåey¾¿=òâ—é:�~¼7åùézQ?ï[†‰^~^áó’Çý¬»qFzùDŒâ”—Žú€¥b/Ïå Ö$ž~bâ„¼ü"ÝÚ´\ýxÜ¾,Ÿ¥ýv¿}ëˆ×-g<Ú7o‡òtMWœ÷—·;RxŠW�÷—ÚÂrIöÇ§GOkžk0
£WÆç%Öûc¯Œy[/Àýý�ižRì —ïC”[Ï9;†T¢M½\!Rc�óuáhoû°u5’^~‘êèã2gÃÛÙéëv¹¿?Þ}Y&ƒ ù®c¾Îà§÷o�ë‚4H/Dº!¤+â­ÞÏ)Óœ^ž¡Ñéa½¶AÅùÃj½ºŸ˜6‚—Ÿ@tžÊy£�g×HË6³¾ïG�æÐÕÃül±õ÷›‡<EXðòŸCd÷îÓö4Ùëñ¶3-)* Pµc‰Oïíåx�\Öë4�ãåx„43P^ž ²	ÊK 8�ó¬Äò �‘8-b?0b(¡1ºÅÍ{gÈ�FÉ÷ÁxyŽ­¾ž�°æœå
QjÌÓ<Ïs1¯—)h?noqÝÂfmß»˜·kœçëûásÎ"Ë¯@]œC†ú>ªÙr™Œ÷¶#L1)Ð])^×Ð·Z×cp¡ü.¤:Ìæ<K�Ú�æ™4+¿	�Oœä~ž†³S¤¼úÐòa‘î/ï'æ)E€ámð²N½¿×OÂ²…9è¸Õ#q‹�nú˜Ÿ¶¹ŽÇã`\R¢Àò=øhqQî^½YÌH,Ò u‹<÷ûÞ=Åd0–+ª…´µTµ»ÃbôPþÈ»`q2°§!Dgù o2Mqz;œ–¶eÂ½¿îg›ÒÓ–qý–É…`ù¸qÄuC¿÷GïqÞBàØÏ¶G-Ë…~ŽÛ~v›®Øü>n»„5–ÿî­gÌs>u¶áa‰­ü½{˜¦õÀyÝ&Ë”Yù‹po
¶Y´q`#ä+'´{=;.–  ÛÂørž5sŽ!*¨üÞÑµØèÜc§òˆ�ìÞ“ÍG¯�s�!iåûÐ5Ä¼rj½UC‘dù14z9\æøðý8ÌbŠŠAåïBr?�!­~¢>N‡E&Xþ+®Ñæ%@µ�ˆ!$ÂX6u
Ó4ÝU�Ö¬¤à´ò#¸Z–R¤÷Ú¨%/îû±ÏËìx´óvx@žç
og•OËÄÓêyV�ózU?Úc˜¦@3–¯0X™lš2Õ÷Ñæ¸áá{?ÄÌdÕQ—)Æ>z;#,Ò¢•¿ Á½£¦—ˆQwÔ"£ÌÊïÂ9ò9õ)Î©V=[›â:Ç³ÕsˆÁ,Ã*¦Í{ï°‚E=æœ»�½w‹1››•ÿ#
‰“Ì:Â´9ÐÚÙšÅˆÙa�×À˜Öfý|ŒÎ)DA§•‰îcÔ)¤)º=¼ö�Ó´G;¢EZ$ÀòÛpŠ�
Sˆð*F-±ü$‘ŽA0Ä(ó#É£•ß€„ï™s"t¢�ÙB´òHƒ@”±ÁB˜M:{Ë‹IprŒÑ-ZJ}4x
1eÔ#aÉŒ X~NºÔÌ™s^ëéˆËæ}œã-¬Ë2ö¾Wg	Y”4 È½‰JsJ�ñØ»°mSbï7–A€å�C‚Ã»€4'…³µæ3"Í(€å3¸õè5+¦öÚ"“ÅhåOB�ÔÕ‰¼zS­ë‰YS-Z™ Èá>2"‡ºÐ,€e�Ž–jJq‰hõBNLn¦òcÈ%Ñl}J3½ƒð	)€e‚àî"²ûyÒò6MÍïõ1‡”#,š8&…�#p¢Ã,D8D–?'5Ðãœ@´1"‚%ÐÍi $A®AÄ�Œ]�Ñ‚¬ü	8‚]aC
õl]6ç¹²ö£kRR¤Xä„	’z°�ÜàÝ£ ËŸ…¢�C¦`†j]qÐ¨òg È18dSÈ
£‚Áâƒ,?€àNà]ð�fD?qÀ¦Ãð

Á›¢-ãÙGÇ2­ jkÃ£GF.B4'�Šð&rZsó~ß»Y
Ñœ X"ä)—'ZhÁ}‚™…r…D9D†aÞaL
ðÑ1HYPù‚‹ð1Z`Î–ÛØåHË4Œzk=\óµ×³ÝÕ##Œ ò¯B¤s¤.Ka†UÞ­“ÁL@
‚Chô�×?Æ–•º” È·Á¦¤©©" &¦jGà’×»÷Á“GQÉÝ‡˜ÂÔS>‚m˜Ûh„hf @J€J‚0ÌDÈ»9 8à´ò�#.!KDòDÆÐe ÞÌ-Í}oÕBÊËg==†y«¡õVƒ“r'¨\à6ÒHÃ¨ár&ºŸê6Mi’jŠ@R€ ˆŠ, Ð¥n”Ý|xŸBZ½5ì´i²0ºzˆ>\³xžîÛ4‡�Ñ«‡0]îç@Œ
¡‡BÊQÖÑ¢0²|A2ó®‘˜b2dø€³›B-xó”9Zßç�{¨£{ˆ!Åô1È(€#"Ë†EÁÌï´Ì Tc“§¦ÚBêY�F/QDA.ù0.wÂà`ID�.‚bp‡;A+ßƒ0Ìï&§±üIÈ,»¼…K‚€ƒ.†LBG„g1%Ê	P š!NLCÇ!†œ`h-Ö)XŒF:e‚ @œ R@¢¥…¡k÷&[ÒvZíûðç%wxÝSfî®ƒ ÙˆÕØ�)N²ÞÎî´b]ŠiNF4†˜éêa$�å_A‰2)ïÁE°,�œ ‚š0L.3¼ýÏÀ÷ÏD�H D@N  ÁYè %Ppš –ªdÐA‡�‰ 2C¤ ‘ ƒÎ²@©ò:èzù]€ b7àÃ\‰t“X"è,D
€H'UfÐA—Q D
tÐK]aD‹É&h4¸Âf"�
%
 Å`ÉÅnÞ)�€±LA
 �eƒîòæiYuìÇÑ}îSH:ÕCŸ©ÑÀ�$¤�Ñ“-“bõÓg’CN Áie�àc¸l"F#ŒÈ–|<‚#‹Fi°ƒ9N¢‚É ïò–DëµŸb´T¾€à^SOa‰´g#DæDÂ�(šfBËÕƒm9·Ö÷ƒÃ2cHæèh†��­±;�$$£‡˜c€%‹9¥ØÇXd° –¢'7 F£ûA`¹@Ç�2³ùèÍèFàj°4Å8üÝÛŒh
^þ2D`Å°åèý¼#*+[Š�­WA!ËÏ!:›bZ#Ôú–�è1Gˆ3X[�“‚•ß�¯„åçÔúþ¨ó”c�YùË�áÝâúñÓýfSŒ)ä8ÑN³%‹å7!Òûˆž×Š¶Ÿ}FV¢—¿Ð~øþ÷€·þ/ðüt	f#ZùÛ ?Ú˜?\'»ýâõžr2ŸçK:í®xñÈi	vàæ–C¤ËÀaCÓ…m�Îœ-–ß€Hg×–—zî�áS0zy‚ ´^Ãõ+çíÛ¯_ýÃ%‡˜¶s´~X1xù
0ÎZ/_|	¼~ûøÓ’0 ýqÚwŸ¶óëo¾®óv™‡‡a,¿^9§ëûy7‹™�tœ!\.ç[¶¥ "ÔªâeMß|ûÍË‰ë†Ð	ˆð³Ù¼\m¿ßÏKq1ã®¦È@z¹@ G?Çü¼Ú~=Fž7 ’|´>§uöqž°œ�j€­Óh£u…`±³üuˆ£F_ÕŽSÁ"-xù)úØG»½Ÿ
iS
S†÷Ã-‡„@/¿�Žzö°>§ñþöi·ËA^„òK�ÂÀÑúåóÏ.xûÃo¶µq *¿•ˆ6v<�¯ÿà0¯—+_›¸ w–'ôQ�ë%�Ûí~"åˆ /ºŸGÝ>^Žó·o1¯Ï‡�RÙ €ÕO-×ìýýõ¨Ÿç7zù z‚ßÝ€÷?¯sž-…‰h"’eÄòSˆÀ¨¡oó8Ûã8R‹ayÚPßî¿HË°!•ØuX~~¶óï¯õiž-çhÞÈb9¢õ8í³Ï¶øøæñm¾lÓáŒ~�óŸxyymó²ˆ.@DkÂºÎãqŒuÍF/_B Tk�_\²ÝñéÆõ2ÝmHå¯@ »ö¾<}Žû·¿xë×ëš�å�@G×ë¤ýýífÓœm½\ Ð[¶=­Øoï‡ok4:Ëo@ |?¾Xãþúº;—5‡�zvä�då—! ¾#ñô1¼~ýÚÇ­kjÓö1[_¾¶N‹»F¶|Ü�÷Ûû9aãSXöþþx$l!ÍF•ˆÈ¢—¯ ÐÛØÓóåùåx}½[ŠiÊÉÇ½z˜°+	’±gúìËñöõ~L[d”ÎNZD,?† 6V†/.ñvûf´¼Í Cåçè½·iºÌ^÷[ïÏ–@zY!ÐQwhû|Åë·¯/X/ó=v >,LKÞûã”Â¤,/¿‘ÞF�Óeåëq"¸,kØûÛÙ-\RÇ¹D·<M'êqDFÑË¨ƒÓ:ñæïU6OÉI/¿�Þ*ÆgÛ†ÇýÎ×iÙ¢ÞÎ»lÊÑè,_B üÑtùÎs¸ÿÑË7;×5v:Ë—ègoyyšq¼¿WÅyÚR:Î÷[ä¶&ÒY¾‚ è1zzþ8Õ—o?ÝÓºF/zkƒ×ë\ßïw*ÍFë,ß…JD¯G¿~ù4õ?ü£_xzZ¦‡*Dú¨ólèûé–2 :ÕÃuÝÇÛýâz	F/+D°D_ŸžÓ8?íçÆ”—mçñÚ™Óänå‘îg‹ùJç{ëSž‚½l¡Ú0]·Àýý½cZ,xùkAT?Òü�KÞß¾>ÞÓ<§Å"Ç9È²Xž ¢÷jù9¡ï�5.sT —ŸA �ÝÃõ²é^_šç�D–D6>"ž÷ã¬}J«!ÐËïAp´7~øþG<ýÁ¿ø¿ôôY:»AåK€Ýóó‡öxùÔ×´èeƒÈá{ðiõ½?ja"G’ÔÇ°å²ðþ8Îó#7òòsôqŒ>¬o¯o{¼\‚“^6ˆP=áâº÷÷ûîÛ4]€ÑÇ®Å²Y/Wˆl¨ÌWäG½=®‹™J„ü<a×)„——ó=N9¥£|4ƒš•ÿ"¨~îóöÂãÓë]Ë6%‹ ×ÞÂ¢ˆôqö±mÁöó±w[r€•¯ bì•éºöóõöÍÛK˜§+jÝo°iqDúYÏ°|1¥ÛëÛëO«9A/?�Ho}ÄùùÊñþöÒÃ¶±$x¥Ù¼äÝû�É2WåæFDˆÎò3ˆÍ¦KB=ÏÎCË!²©µéé²œoûmÃâ`‰ð^.ÏOÒëñ^¯yNÑYþ<¤ášÂÌX:ç˜Êï@¤÷:Æüü„þòö~´ySåW >–Ë8nu‡rÚh½Ÿû9â2™©Dx5N—~¼Z´ÓLÚpLÁËïC¨Þ‚=Ovo·£á7G(Ý}äËviçýìÄ¶*–A~XMë6ûñ~Lq›C,Ï�W!MszÜÃÂ hìóÇuööþ^ãšƒPµòbï/ç¹¤ƒ³<AÞªæ|�~«÷÷1Ï¶`‚É� À²³ü¼û@X§±×s×H)±\!²†=M—mÓÛùÞ�œ–„P"Æ�azžÒ}?Z¶r}´ „�å—à£–´UÕ^‡"H@Þ<„<Í;›€)RùDv?èÛÇ/Ÿ^ÞïÏó:û‘»z�åï`ð”¥)…Êû	¤ÈH£wåüÌxï9¤`Ë„a‡!,1©ï÷QmYfôv<ÎÖ,Å¸(‡�1¬!Àk#0äaVžá£*Û– º×=(3ƒ,ˆÂY™.[oã½ïÌÓº ûÑ÷S1Xt²\ 5tÄyE«ûÞ�C6C(?†{æ9vîý$-$±<AÿAðÓj[—�üyÆ˜s®µöÞçœ{ßº¥¦J…**%ZÆ¤¤HÀ�¤ÀN(±bCP±{�4Ò±kc5±¯]?€Á/!Ñä}ï½çœýg­5ç�¿ŸÆ0ðÅ¨þ¸�ªÓ)¹�ˆ-Á‚	¤­ÿ"cŒðr>%FZSÁõD cmùXyÜ¿¼ï˜æ©•ÑeXKEíÁ†’æëß�FFŸÚÙ
îÇK3T‘ë�!¢kÏz~ñú~¼XxªçCÄHk´èÑ�sYj!4zÉI.#mý	4ØUë¼¨]‡XŠÏðÀ1RNOB=¥ùäöÇuŸpš¢qý»”}€íô¼Dl·ci¥ºÜ(®	ƒ{_ìƒ¦1¶Ç½yiæ yZN˜c<Þ8š7zÀ@[e„{+%F×aô,i\Ÿ¡aÃP›•ÌTî•GuŸ4¶CVëÔ¬ÑÃ½ªÐŒ\ÿÂ�0úÒ8ú~Ü—œŠÓÜ@[)£Ã|š
Æ¸ÇŽÉëì@>"9Ó­8Àõ·‘1†ašÝŽØšY�y‚ëoBBÆUóyL×q»gNôR�&­–,ƒÑD²œP…n�¬µÎŽøSTŒû>ˆyB #1/K¢ß·�Ó4YÄžì…fžàú¯‘Ê]°©MÇÈãkzŠmýÉ(6µyó-YC5‘	p� (tpø4¹Ù6&c¡\ÿ1$ÅAN~9iÜ·cÂyjV�#ƒ‘Aãúo!iddñ'F¿?n›û¥5–G9¦(#@Eìáu©Kôñè‹šPtÀÚÔ(íã¨…pˆ¶~‚È£¢ùDævˆðy®�ýqà˜Ê\Ý‡ºÉ×ÒJk‚vìîrÆŒaáµV½›æÚÌr™™ÅT¯£–É‰Ž]-‹(Úº@1:Øžl·Ûö6Y©Våfâú[X‹ˆT7CYÜ£÷±Ã—R‹\yÔîB1Ò0‚nV[¡ÔnNJÈ}ôzš/¿<®×ÝZ½lm`­ÀœÆDd·¼Ô3t¼÷ûÉk1˜´[iQ%°6?×|Ü×amž‹27§ÑTd´Î˜Êîi“ëC”ÃH(;“óäRÏ‘f…æÆ	”÷kËÛ±oÇ4—êPtææ™k�D¦:F,çZ•�û;Ž¥ÌT§ZÈå	&r¤©NNŽ-…¥:&­�Ô©œvmû#­Ye• ­?� Ês„fMgÄ£¿¿ÇT¦©Â"Fz@ææ\!•é8Þ)¯‚3™Ö¿z6o‹+ã ²À€^êÅ8öû!c19Á¥]ª©¿õÍYYB´u† ‘RF—¡µ
ä=v›lªæcd `Å<jJ
Èj-1zM§9!r0{ÃTÌ²B6NaÂNkæÀA�NTæ`d±ã®¤`f ^Í‰Ž‘¥´Þq›-¥+è&Oó´ðŒymŽŒÀp9@H0ÊfËiŸ·¼â(°Ê’„\	É (Í¦¥ cËƒÍÏò ¦„9\Ðz‚ÈD0aÕLÇ„R¨Ü{•YK3­$B@†ú‚Òh]½�Í“ÝEÀŒ Ö#	�òi*ˆÞ¡,-$¤<"ÁÌìðR&WîèENPàúUÃC’•º”ˆ{GÌµ–‘û`°¸þk€�Ìæ™À±ïÈVf‡ï8`Ž¢2”�H­ÏH‚€ŽÕ§Ârd–n•0K2i	ˆÈ�H/M®NMJÃ2�f\HJ’–CäÔj‡™UP.r Ù|¶ci6Á ˆ\?"	(sÈŠÍð¾åásYÌ3wJÅ'!¤ÌÈõŸB�JxaMŒ4JtZñŒ­�¶°D>zälµ$àú[�˜2“¥"¼¸+2Y¬`
…�Œ¤(hý)„@!3#Y&c:Ñ[ZsŠÝ… L�psóÔ ÂI!‹Ò†FX‘ÑH€R4!%%@(‡’éÖ[š¦6Ú�ÅXÍEÈ@OÙú$€Dkq¨#	˜“SBiÕ,°gñ:¥Ç�‘(æ$À0×¿¥R 5‚y˜Ë¼HK­?…2‘¤ L±`
¢s ˜„&)J�ètCŽ,á4®E	¢�1ænÅ4l”	
!@Äú_�ÿ E1ˆ•T¡ @dÒ`Z8 1HLZZÔ„ A¢ QÄZ(HH “¡µ‚	&¨“ ˜™dT¢@³âV !AÀ©µ‚	&&A  s=A¤D&A&)FU‚	*i	0!!¥”hU^@„†fÞX²(„Ã˜	¸è\+˜k…Ö&)PZDæ:AÀ(T’Ipm�áé*†ÂÎ.s­¿	)XeÒÑ2Mäú�”!zÓÔy°¤\,€„0 °ŠCÀ¨ qýU
nMÈÎ�àúKHÊ*Zj$C4Ò„Q‡ÏÅc''#‰¶qÛr²F3¤ŽÉÚØpxiÖ`žë¿„ä‘Âôréýúzä´g D@~:£_·½bn,)@LÛ›OÅ¶ÇõôÙ\Ðú+Ü»ÏÏç9nÛ½×¹žÂÅõû = åÉív»ß/ev¡õÏ 0cG=½Ôýíþ­÷s�d	­O¶Cåò¡íûÛÃj«Ïî·ñ~ToÍAh=A€zÊŸÎÖ¶íÆ£�ŠSÐúPlPùÐ¦ãøü>ÀæOuÆ±Ýw³¹ÀHíní<Íý¸n}*µPÐúë˜yˆOçÂ·ñº»›�NóØoïoXj­	h=A`æÞë¼\FÜÎ“˜ë?„dÇŽ§�t½~·Û©Ížâú×  ¹e_žÏc{ýÚË|j€Dä£cþôò>n_ÓÛÅªZÿ´ì¡éÃù¼½~ù²ùå\o´þ
Ò¤Ñ7>}ïÞÞ¾¼á2�vyŠë¯C ´ß³}8çöí×¯ýùi“Ql�¡µ ÇàË‡2ÞÞ¾Û4;?_p¿~yÄtvÊ õ7 2ÔÝçFŒx:Í™ë„ ÙyY–|»¿?Z��Ä°=OŸ.|¼½>¢>Mk�Dpè@}š³ß·Û˜çRÐúàHôç3ý¶Ý l~9ùõñù�¹-)ƒÖŸ@ rßÑž«ïÛç-§Ú�€Öß‡dŒ{Ïåo||zûËÏŸ—öÒÊá�õGðù÷ë—Û�—ÅC€ÖïC€8²—O(_¿|wÓÓe°3ÅõO ™u<ZûtÁõýË{œ¦f	hý1D0‘˜§–8¬Î¼<îWùe)–Ðz† Ä1lþf±ííý�ËÔDIë€Ö‚>\p¿~yoÍ¦ö¼`Û^·hS5JZÐ‘¬/Ôûq{¯¼¸§¸þ1Dt¯³êž�l^‚€ÈÌã4;úH«ÍÓÖBà°Gñv	>" ŽËTÐoÛÛ‚Ò–ËÙûÛÞmjS”PZR)Ú©ÚÑ�È©ÁœQèØ|¹\¶ãýj/m¡DäV?=o·ûwŸïí2³{BÌŒ8�/¯÷·¾<Õ
@2@[1_ÚÇ­³Ï6=Cïýá8×J1Š‡¶czúØâíõí€7ž>åúõ¯ÞÞÊT///x|ùú ½^¾Ylÿ«¿ü‚e>í–ŒbëoB C[·§�÷/GâùT»+Eä–}þøTîoßÅæ5ÛéâãíóÛÃ.'sQZ"sHœ¦yáæ5‘‰c�òÔ&}þz½Ïhõ{Ë|½~÷Ýç¥´é›å|ýî­?–¶œŸÑïß]ö<Õî’Ö_ƒŽ-ÏÛí9ÏE…	‘1Ò¹Ôat4oaëÿ€*�,—©õÏo·­,­eBëÏ!ûèöòÍ%ö×ÏÛã©�¯ž)8°û4×û¸Š<³0©b¸ãôr~×ûõmO›ÏÏ/ÚÿÏýKÔe!]yú¸àz½“ez>?µ¿øúùËù›ó¦¸þ!$¼ï~y¹äëÛwï†S==½ Þ¾¼F[fÐz†Jû¨§oT¾½¾Þ8/40×ŸCdäaež
·ÃZˆˆãðúé\ÇöŠ]¹,ŸˆoÿâÛwÏçééŒóþÿ¾ü_NÏÐú#LÇÃ/Ï¹~»ãÒÎ@Øñ¨Ë7ÏÜïïée:	Æ\ÿ=DàÈÞNË´�÷{emæƒëïBDU­Z9:M¥º"GŒv:•­¿ß’mBÆè<Nm¶‘Çd©ç’ûí¸{=UO2×¿�¾\ê=^{àâÅy¸—E–[/¥Ás}�(Õ©1c3s+ëŸCdÄÈ6Mî#²XyZ·ÇÛ¥-ÖR\/˜±I——oo·êç9a DRY>´c¼>6\N-<¹þ6fnóË‡ë~ûúå/OuŠ÷÷[·s­0@äÐ†ö2M�Ûþ¾�\žŸêÿ½¿~éOË	pý/1”/Ll=k£OˆÌØØÊ¥ðº?Píd5È”1;{™&W7+sý#ˆ`pDýæ|Ú¿}ë²i9-û—×ë—Û°©¼,Uûõím.Ù‚Ìu‡ÈÌ}Ïú4ûþö%®e9É‘\ÿ”#ÍÛ¤Œ-´×úˆÌxhÔ�µlÇ«†-“\kEàuy¡_o¯ûR'¯Iæú?¡ì`)s¨+‰‰4[¤H³V±3›htØ^ÊKåûö
°. ™ëO Fy¸�k>ö~�Ki…±þ"Gö\–§¢·Ç.TŸÒ•ë„^�¥NÆÜby×_B9¢Ù©Ñv<lå\ ÇþŽ¨­ª‚	h` Öf}<ÅMfëßDF‡Íµ!·xÚt)[Þàó„ºþ-(÷—ö4z¿?6zñ’\? Õ«ju½ÇH÷éRxì�Ž©UZ2egŸlÒ,·äúÏ¡²R«+pd3kÉõ§ÈÜ£âÜòÚ•â.®?€È{ÖËGÏëýõ8M,I yàðúTò±¿oS›¾>C8²s:{ëûíJpªfÉõw‘êÅg©3Å,pBÑKyÂ¤·ÇãÇÒNVxŒÇ}ÂÙ'ŠëŸCê²þ|*SÏ¯×}žË™–\R·lešÂîq=P8•4[ÿR‡Á§–Ð¡ÞàN®¿e?TçËÚ^ß�ÞÚ²LÅ®ýž{eq³°„4ª“jÄ�,²J3)B•ó2Û½¿…ÍÉlý)‡¢”yŽGÞ÷=­UÖ°(™æó	6ÆvHµXI³õ!†yšòØ·cóâ&&Ù¹•2�Ñó¸=Bµƒ¯¿!šË²è8n}�­ÑÀõ‡�†g6q0cK³õ@B·èËi9GÞûmälgyr}FÆ(§3q=®ý~¶óiòÀ±]ëŽe:9=¶~7M´õ{HhH‰¹-åû¶	K)p#�6j�ä9PTP€2P­YbGÀêÒ
9ö‡¡Î6=ò8v+˜’\Ÿ‘&›YÅžHƒ¹ùú„àµª�CˆŠy*>pid-0®ÿ
ZK˜·B6Áéym)ó�÷Cªsižä*¬ÏPd¤&x�0”äú©TšM¨9rpÊ©ÎTï£'|)Ó¡<®}ø2ŸÑ9[“WTàZ!¤RTo§Þö~ì7Ãy>¥Åxß·´ói6ŒÛ6 ¯fò¤­
!•‰:YáŽ}˜ªUs®gHÊ8
J�-¸�^dS€ë!<ªüdsŒ-{V¯r2	hZÚˆþ=«&5×?C"<ÌË4i?Æ»:f¯†š´õ	áÖêI§ÁŠ­ÿ’2‡zÃ¹¹nÛÛg›½ 
c©4ŽØS­02³…YRÔúG2sÕš‡6W1£_/�˜¡d™ÌC{M:ÌÖŸA‚#!ŸžÜ¶ãý€O>;¬P  	�8„˜—eÊëxßw±ÎšÆõa­ÉÉX;:@3rýaBŽôÚÎG}lÇ,µ8Ì(®
!±–T±JêÁÎJ'¸þ'¤�*™8UzŒ-Q¸´‚ÈG²Âè$DÐÖŸBHÁdI÷jàQG1§H„‡Á‹{ªk4‘æÔú¿!!e†ÉëDà8†�Fjýû”TUìä2ÍŽ÷èQPI3­\ÿ	% 4Ñzéfó¢ºÇÃDV7 e×AH„U†x”±Ln}ç€£´ Àõ‡X‹ #r XNÕ|l”k…C2A$@@9yÑŽkdSS%e§lZdÜíá•ÆmýÏHr7Ë8šÏu‰ØYÝ«Ì˜Më� ”ä(!u‡œf™C”¹~Êµ!0“MiGŒÝ©‚ª\‹,ië ¥„¹Ù@ÒK+™=Ä
—›A`’IUÈ2‘t«Ra¶þ#H(eÎ‘]›YÃ»%KÂÍ)¤ ¦¥¸>A„(% 7gv œ¥$"³ÜŠA©!rý5H A@P"S‘+®?€¤¤Ñ
ˆH$]b
 &	„ÀÊäÌxÈÔêT8ú‘9É«Ì3ÅDX[!!@Ãlª…£T³¦	É(L0!®ÿÂZny°¡±ÁpøQ"ÌÜ%@HKZÿÿ^!­BASE      8þ  xÁA  ƒ°Yãx` þµ,9a6Äiªla«¬Q¶†µŠšc’È9W¨¸ÜpåÆØ`N£"TÈ•#s¸A´,Íˆ1g°YLS�S§ªªÛp¥Aš[Á ´Ö²mÍ1ÖÆ¶)ÊØÒæ¶•°•Z€®Ô57·0’MGÕÜ¦:g
,¡æÚ‚5[P�´é\AnnA6×ÈP·%%Y ªèÊ�Z:—¥ )¶Æ †è(KUZŠm-ÚŠÑÖ
ˆ&°rN'dc„*K%¨¡ÊÖXÅ\ÌUé¬%²Ü†¬µ�fÔ Ø¥ª�b¶Ú6Ý b,c¥Êj‘PE®M´jµT¦«¹Â2l€¥m’­i•QKtXB.ÔMæÑr©•®TuV¢.tX¶ Ú$m¨!² 
L¬7BPOS      <  xÁQnTD±‚„JÞøÜ´!ÖÃÛbéØÿþ÷Ï/ß¾}ûõããÏ¯ýñþúþw_ùÙöý>ïÇGÞûíÃÅ=¯5ö×½>Ú^�zµ–vg¶é´ÇS§Ù¼Ë<Li÷4uµžžÒ™„ÑÒ»u­çÝ.žº½À²1†5æZ°e�¬ 5Z›íÆ„ÇXPoÖ’†0jM`2Øb6°fA‹iZkk€µ# ÖÒ€Aši�À†fd¶ÍF,!&¦iÇ4c„À´fÚ�ÚZÌdÄNÆY;�`ƒ`Ò"Â`Ð¢0S•–€´™ÑœÁ íYAo±ÎAÖ4š-­í6/¿oKÖz½{­I[÷<ÚêÓ¢Í[`²:£íî»çÞ^ŸÉ>·¯ÇÎ~
QkùÞ­á^Ä‰¹ùø±ñ?>V1CNF4      ]â  xÁÝnÓ0€á×qÜ´éOXT6¥Ò„&Î¸†ÝÀw¼Kç��
…²ÖmòÅ6Ïc.È£¡4Ù¸M6Æ¾ÿ·y5»|=bö¹]�ùš¶ú¶÷lC#¾†(ÛZD­<àédƒ§“<�¬ðt²Àwò†ç{i‰X¹!b£•šc#{"`å‰V”c#w¨“5ªÔªµ4<ßœ“5ªÎÁ—ýtà�ïdN¨A¥ßö{@}Ó@¿U'sÔÉu¨§Qó—ë¼óˆ	U;p@$¡8
lÄÆÐ˜ß´Ã¹¡Û°C�^À¾íïpÁ�‡ÕòÌZ�ïÓë?Q§/‡È¢°T)ÔÅú¡ªÇâ˜X·¿n�ƒ»ˆU]L»ÃËú¼°§´Ì˜)7)º“ËS9‘&3W'nÎCK£Ñ¥s&ÿ,‹²¼NÅb˜H&®’‘Œd$#ÉHF2’‘Œd$ÿÊ¨²TEXT       Ú  xÁMNÃ0Ðï(s€ÚÏØ˜DÊÂI¬ÒæWi¨`©lº(*Âùyc2Ð§1C.§ãˆT¹ zh*÷ê^Çª`=¬•�q™S¬„6­ë}'a:ïb)CQz%aQú}ÒzßI˜ÎûƒØ—Î—>�°(–÷±…°(GaË
¯dHX”£°eï¼h?óŒ®Þ4*oó4Ç­n×?µßÏ†Ô¼á#«9M«v…Ñ¨l¢Q•B³b˜Ú•Q7©GWÛÛ×®yq–qÍ‹ «ÉYþaÓ8íCLIP       	            ¯<AlignableSequences trimStringency="Medium"><Sequence name="117_CMV-F_TSS20230719-027-06802_F03" ID="0" isTrace="1" sortOrder="0" trimmedRange="9..1015"/></AlignableSequences>  ‹     ÿ BC N srôe”```pðpáó³2Ô3ãö·²*Í+Î/*IMábÊqqQjZjQj^r*ƒº ’Zæè6   ‹     ÿ BC œíQ=n×1ýµHì¶,‘[<vc¶å!lœ†‰D22p ŽÀÕ8 *þ—JÀèS’Ä~r>½¾žðãþºîßã›¾ÿ|uýƒ‡ëkŸßß]6¹{æë7_Ïö·gûso¹ñÝûÆžùá¯¼�½yèb“>®•:)æÄ¬¤ic@™Y[¬8Ca¬�nlƒ’P *VÄ²ETª4†)õ­"{Ë–†�Þž+„Zù€”¬ÒS{­:ãl–1J¦�
¨¢u�
©}¬Ðcl£ìð­b0$·ÊYP{:9ñÜ­¢³Á;HŠrŠ“#¡% ¥"Í0‹€`­µh Z E2£ðlï™>Ë×¬rðÙ“‰½�I×a„Lëv%ì4;ÿÌ‘¾kX¦ì,æ²ƒcÎCÛó @ë QÌÄ™ç´¤v£×€UÑ]¹¦dx’Í�š3»þ¶Üå®´épÿ�¤ÒÓ�†Éd.-iD�þÑ¼MNL“;$K£G”ýZ—(âp"ûø‚¼àÿÄ/Ý ÆŒ~  ‹     ÿ BC             !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  $n<?xml version="1.0"?><Features nextValidID="18"><Feature recentID="0" name="AmpR" directionality="2" translationMW="31558.16" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" cleavageArrows="6490" readingFrame="-1" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment range="5699-6490" color="#ccffcc" type="standard" translated="1"/><Segment name="signal sequence" range="6491-6559" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="MSIQHFRVALIPFFAAFCLPVFA,HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW*"/></Q></Feature><Feature recentID="1" name="NeoR/KanR" directionality="1" translationMW="29048.78" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3403-4197" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="MIEQDGLHAGSPAAWVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADRYQDIALATRDIAEELGGEWADRFLVLYGIAAPDSQRIAFYRLLDEFF*"/></Q></Feature><Feature recentID="2" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1532-1534" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1535-1537" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1538-2251" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="M,V,SKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK*"/></Q></Feature><Feature recentID="3" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="945-1519" color="#a6acb3" type="standard"/><Segment name="ATG" range="1520-1522" color="#a6acb3" type="standard"/><Segment range="1523-1531" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4943-5528" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="f1 ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2565-2993" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="235-614" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3007-3336" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2295-2519" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="615-818" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3187-3322" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4371-4492" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="AmpR promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6560-6664" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="lac promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment name="-10" range="4589-4595" color="#ffffff" type="standard"/><Segment range="4596-4613" color="#ffffff" type="standard"/><Segment name="-35" range="4614-4619" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for the &lt;i&gt;E. coli lac&lt;/i&gt; operon&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="CAP binding site" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4634-4655" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;E. coli&lt;/i&gt; catabolite activator protein&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;CAP binding activates transcription in the presence of cAMP.&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="T7 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="863-881" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;promoter for bacteriophage T7 RNA polymerase&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="M13 rev" directionality="2" type="primer_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4541-4557" color="#a020f0" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;common sequencing primer, one of multiple similar variants&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="17" name="lac operator" type="protein_bind" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4565-4581" color="#31849b" type="standard"/><Q name="bound_moiety"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;lac&lt;/i&gt; repressor encoded by &lt;i&gt;lacI&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;The &lt;i&gt;lac&lt;/i&gt; repressor binds to the &lt;i&gt;lac&lt;/i&gt; operator to inhibit transcription in &lt;i&gt;E. coli&lt;/i&gt;. This inhibition can be relieved by adding lactose or isopropyl-Î²-D-thiogalactopyranoside (IPTG).&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
  •<?xml version="1.0"?><Primers nextValidID="2"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/><Primer recentID="0" name="R1" sequence="aattcGAGATATCTCGCGGCCGCACTCTTAAGTAGCG" description="&lt;html&gt;&lt;body&gt;&lt;/body&gt;&lt;/html&gt;"><BindingSite location="899-935" boundStrand="1" annealedBases="aattcGAGATATCTCGCGGCCGCACTCTTAAGTAGCG" meltingTemperature="69"><Component hybridizedRange="899-935" bases="aattcGAGATATCTCGCGGCCGCACTCTTAAGTAGCG"/></BindingSite><BindingSite simplified="1" location="899-935" boundStrand="1" annealedBases="aattcGAGATATCTCGCGGCCGCACTCTTAAGTAGCG" meltingTemperature="69"><Component hybridizedRange="899-935" bases="aattcGAGATATCTCGCGGCCGCACTCTTAAGTAGCG"/></BindingSite></Primer><Primer recentID="1" name="F1" sequence="ctaGCGCTACTTAAGAGTGCGGCCGCGAGATATCTCg" description="&lt;html&gt;&lt;body&gt;&lt;/body&gt;&lt;/html&gt;"><BindingSite location="895-931" boundStrand="0" annealedBases="ctaGCGCTACTTAAGAGTGCGGCCGCGAGATATCTCg" meltingTemperature="70"><Component hybridizedRange="895-931" bases="ctaGCGCTACTTAAGAGTGCGGCCGCGAGATATCTCg"/></BindingSite><BindingSite location="920-944" boundStrand="1" annealedBases="GCGGCCGCGAGATATCTCg" meltingTemperature="41"><Component bases="ctaGCGCTACTTAAGAGT"/><Component hybridizedRange="941-944" bases="GCGG"/><Component hybridizedRange="936-938" bases="CCG"/><Component hybridizedRange="920-931" bases="CGAGATATCTCg"/></BindingSite><BindingSite simplified="1" location="895-931" boundStrand="0" annealedBases="ctaGCGCTACTTAAGAGTGCGGCCGCGAGATATCTCg" meltingTemperature="70"><Component hybridizedRange="895-931" bases="ctaGCGCTACTTAAGAGTGCGGCCGCGAGATATCTCg"/></BindingSite><BindingSite simplified="1" location="920-931" boundStrand="1" annealedBases="CGAGATATCTCg" meltingTemperature="41"><Component bases="ctaGCGCTACTTAAGAGTGCGGCCG"/><Component hybridizedRange="920-931" bases="CGAGATATCTCg"/></BindingSite></Primer></Primers>
  Æ<Notes>
<UUID>cac14035-4064-4913-b4c5-ca768398b1f5</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-MCS-IRES-EGFP-Neo</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created UTC="1:38:26">2023.6.15</Created>
<LastModified UTC="0:30:8">2025.9.21</LastModified>
<CreatedBy>Triple Threat</CreatedBy>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
</Notes>
  Y     K         
?????                                                                                                       ÿ d      DO ÿþ              E              ÿÿÿÿYô? P                                                                                                                                                              µ<StrandColors><TopStrand><ColorRange range="895..931" colors="light blue"/></TopStrand><BottomStrand><ColorRange range="895..931" colors="light blue"/></BottomStrand></StrandColors>   3<?xml version="1.0"?><EnzymeVisibilities vals=""/>
   )<?xml version="1.0"?><CustomEnzymeSets/>
